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Executive summary 
Policy context 
In Australia, diabetes represents a major burden in both human and financial terms, drawing heavily 
on limited health care resources including trained staff and carers. In contrast to many other health 
conditions, evidence suggests that many aspects of the burden imposed by diabetes could be 
avoided through preventive measures. Type 1 diabetes mellitus (T1DM) is a genetically linked 
autoimmune disease and there is currently no known prevention. However, the risk for 
complications associated with T1DM can be reduced by optimal management of blood glucose levels. 
Type 2 diabetes mellitus (T2DM) accounts for over 85 per cent of all diabetes in Australia. Obesity is a 
major contributor to the development of T2DM and weight loss has been shown to reduce the 
incidence of T2DM in people with impaired glucose tolerance (IGT). Therefore, primary prevention of 
T2DM has generally focused on weight loss and lifestyle interventions, while secondary prevention to 
reduce the risk of diabetes-related complications centres on use of pharmacotherapy in addition to 
diet and lifestyle interventions to manage surrogate markers of complication risk (e.g. blood glucose 
levels, blood pressure, and lipid levels). The aim of this research is to examine diabetes programmes 
reporting outcome data and used in general practice settings to identify and proactively manage 
individuals at high risk for developing diabetes; or where diabetes is diagnosed, at risk for 
development of, or deterioration in, diabetes-related complications. Comparison of programme 
structure with published evidence is used together with outcome data to assess programmes. 
 
Key findings 
Based on our review of the literature we found that for primary prevention of diabetes: 
 T1DM  
o There is currently no evidence-based method to prevent T1DM; thus current 
guidelines do not recommend screening or preventive treatment outside of defined 
clinical studies 
o Current ongoing efforts to identify prevention measures for T1DM are generally 
based on preserving pancreatic beta cell function and this has shown some promise 
in small sub-cohorts of patients with a family history of T1DM 
o Ongoing trials in the Australian setting include TrialNet. 
 
 T2DM  
o T2DM can be prevented through sustained weight loss in people who are overweight 
or obese, adequate physical activity, reduced fat intake and increased fibre intake 
o Adherence to a Mediterranean diet has also been consistently associated with a 
significant reduction in the risk of developing T2DM despite minimal weight loss but 
this has not been adopted in current prevention programmes in Australia  
o The AUSDRISK diabetes score is used to identify high risk individuals in T2DM 
prevention programmes in Australian primary health care (PHC) settings  
o Intervention programmes aimed at reducing the incidence of T2DM largely draw on 
targets defined in the Finnish Diabetes Prevention randomised controlled trial (RCT) 
study, which included the following targets:  
 sustained weight loss of five per cent or more 
 increased physical activity to at least four hours per week 
 improved dietary patterns 
o Based on RCTs, weight loss of five per cent or more is associated with a 58 per cent 
reduction in incidence of T2DM  
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o Most diabetes prevention programmes in the clinical setting are based on lifestyle 
interventions but to date these have not demonstrated weight loss comparable to 
that achieved in RCTs 
o Currently most programmes implemented in the clinical setting lack sufficient follow-
up time to observe any impact on incidence of T2DM  
o Cost-effectiveness analyses based on outcomes from the US Diabetes Prevention 
Programme (DPP) and Finnish Diabetes Prevention Study (DPS) RCTs may over-
estimate the effectiveness of lifestyle interventions compared with ‘real-world’ 
interventions 
o Lay community members may be as effective at motivating weight loss as PHC 
professionals and this is likely to have a major impact on the scalability and economic 
sustainability of diabetes interventions 
o Australian prevention programmes demonstrating moderate but significant 
improvement in outcomes in the PHC setting include the Life! Taking action in 
diabetes (Life!) programme and the Sydney Diabetes Prevention Programme (SDPP) 
o International programmes demonstrating significant improvement in outcomes 
include the UK-based Counterweight and US-based SHINE programmes 
o Ongoing trials in the Australian setting, but currently lacking outcome data, include 
the Mothers After Gestational Diabetes in Australia (MAGDA) diabetes prevention 
programme trial for gestational diabetes mellitus (GDM) prevention, and the 
international PREVention of diabetes through lifestyle Intervention (PREVIEW) study 
for T2DM prevention. 
 
Based on our review of the literature we found that for secondary prevention of diabetes 
complications: 
 General practice-based programmes are particularly important for people withT2DM, and for 
those with T1DM and unable to readily access diabetes specialist services (e.g. rural and remote 
residents) 
 Both T1DM and T2DM secondary prevention centres on modifying surrogate markers for risk of 
diabetes complications: achieving good glycaemic, blood pressure and lipid control 
 Systematic reviews have identified key components of effective T2DM diabetes management 
programmes as: 
o Team changes. Changes to the structure or organisation of the primary health care 
teams e.g. upskilling for GPs, or adding nurse specialists in diabetic care 
o Patient education.  Interventions designed to promote greater understanding of the 
disorder or to teach specific prevention or treatment strategies. 
o Case management. Any system for coordinating diagnosis, treatment, or routine 
management of patients by a person or multidisciplinary team in collaboration with, 
or supplementary to, the primary-care clinician. 
o Facilitated relay of information to primary clinician. Clinical information collected 
from patients and transmitted to clinicians by means other than the existing medical 
record e.g. referral systems, patient passports 
 All of the programmes identified in the current review included team changes and patient 
education, with some of the most promising programmes including social or mental health 
professionals in those teams 
 Programmes demonstrating significant improvement in outcomes for people with T1DM and/or 
T2DM in the rural Australian PHC setting include the Rural Australian Diabetes – Inspiring Control 
Activity & Lifestyle (RADICAL) and the Point of Care Testing (PoCT) Mallee Track programmes 
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 Australian programmes demonstrating significant improvement in outcomes for people with 
T2DM include the integrated primary-secondary care for complex diabetes model, and the 
Northern Alliance HARP programme 
 The Canadian St Josephs integrated care model has demonstrated significant improvement in 
glycaemic control after just six months 
 Ongoing trials in the Australian setting, but currently lacking published outcome data, at the time 
of writing include the Diabetes Care Project, which is due to be completed in 2014. 
 
Policy considerations 
Primary prevention of T1DM is not possible currently, but ongoing research is required to assess the 
feasibility of pancreatic preservation through dietary and environmental control. 
 
Primary prevention of T2DM has been demonstrated under controlled trial conditions. However, 
implementation of lifestyle interventions in PHC clinical settings has failed to achieve similar levels of 
improvement in established, surrogate markers for diabetes risk. Longer term studies are required in 
the clinical setting to assess the impact of these more modest improvements in weight and physical 
activity on the incidence of T2DM, as well as the impact of alternative strategies such as 
pharmacotherapy and surgery on modifying the surrogate markers. There is some evidence to 
suggest that delivery of primary prevention interventions by lay-people achieves similar outcomes to 
delivery by PHC professionals, this is likely to have a major impact on scalability and economic 
feasibility of lifestyle modification programme delivery. 
 
Cost analyses in the clinical setting are often centred on model based projections utilising data from 
RCTs, but this is likely to overestimate cost-effectiveness because ‘real-world’ outcomes are more 
modest. Inclusion of in-trial/programme economic analyses should be encouraged in the future to 
gain a more accurate assessment of the cost of delivering lifestyle modification programmes. In 
response to the more modest improvements observed in clinical settings among those at risk for 
T2DM, it has been controversially suggested that in the US, national policies aimed at reducing 
overall consumption of food in the general population might have greater benefit than lifestyle 
programmes specifically targeting those at risk for diabetes.  In view of the strong link between 
T2DM and obesity this suggestion has some merit, but would depend on the scalability and cost of 
broad-based lifestyle modification programmes, and /or the potential of other measures to achieve a 
general reduction in food consumption. 
 
Secondary prevention of diabetes-related complications in T1DM and T2DM in the PHC setting has 
shown considerable success based on modification of surrogate markers of risk (HbA1c, blood 
pressure, lipid levels). Programme structure varies in line with patient needs and clinical setting, and 
this is consistent with calls for individualised patient-centred care to achieve optimal management of 
diabetes. It is unlikely that a single or limited number of programmes will meet the needs of all 
Australians with diabetes. However, programmes reporting significant impact are generally based on 
care provided by multidisciplinary teams (including social and/or mental health professionals) and 
targeted education of patients and professional staff. The expanded team of care providers will 
attract increased salary costs but these may be offset by improved glycaemic control and hence 
reduced cost of complications such as diabetic foot amputation, cardiovascular disease and renal 
disease. 
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Methods 
A thorough (non-systematic) review of Australian and international literature was undertaken to 
search academic and grey literature sources for relevant material published between 2008 and 
September 2014. The databases searched included PubMed, Google Scholar, Scopus, PHCRIS PHC 
search filter; and publicly accessible websites of relevant companies and organisations including 
Diabetes Australia, Royal Australian College of General Practitioners, Australian Institute of Health 
and Welfare. Two specific programme areas were targeted in this review: 
 Primary prevention of diabetes among those without diagnosed diabetes 
 Secondary prevention of incident or progression of diabetes-related complications among those 
with diagnosed diabetes. 
 
Where possible, a distinction was made between diabetes type: T1DM, T2DM, gestational diabetes 
mellitus (GDM); and where possible on the basis of target population (e.g. general, Indigenous, high-
risk populations). International programmes were only included if they were directly applicable to 
the Australian setting (i.e. Canadian, UK or New Zealand programmes). 
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Background 
Diabetes is a complex, chronic disease that represents a serious burden in both human and financial 
terms. At least one million people in Australia have some form of diabetes (AIHW, 2014b). Under 
normal conditions, insulin secreted from pancreatic beta cells regulates metabolism by controlling 
the uptake of glucose. In people with diabetes, insulin is either absent or inadequate levels are 
produced, and/or cells are resistant to the action of insulin. A direct consequence of this is disrupted 
cell metabolism and accumulation of high levels of glucose in the blood. Type 1 diabetes mellitus 
(T1DM) and type 2 diabetes mellitus (T2DM) are the most prevalent forms of diabetes; and T2DM 
accounts for approximately 85.3 per cent of diabetes in Australia (ABS, 2012), and 90 per cent of all 
diabetes worldwide (Diabetes Australia, 2012, Colagiuri et al., 2009). In addition to the almost one 
million Australians with known diabetes, for every four adult cases there is an adult with 
undiagnosed diabetes (AIHW, 2014a). A population-based survey in 2000 showed that when those 
with pre-diabetes (and at high risk of developing T2DM) are taken into consideration the prevalence 
of abnormal glucose tolerance is almost 25 per cent (Dunstan et al., 2002). It is estimated that by 
2033 approximately 3.4 million Australians will have diagnosed T2DM (Vos et al., 2007). Beyond this 
is the considerable personal burden to individuals and their carers, and the impact on communities 
of high-risk populations such as Aboriginal and Torres Strait Islander peoples. Indigenous Australians 
are three times more likely to report diabetes than non-Indigenous people (ABS, 2013). Contributing 
to the more than $6 billion annual health care costs of all diabetes in Australia are the average per 
person cost of $3,468 (T1DM) and $4,025 (T2DM) where there are no diabetes-related 
complications, increasing to as much as $16,698 in people with both micro- and macrovascular 
complications (Diabetes Australia, 2012). A recent audit of inpatients at Melbourne hospitals found a 
diabetes prevalence ranging from 15.7 to 35.1 per cent in different hospitals (P < 0.001), and 
complication rates of 71.4 per cent for any microvascular complication, 52.2 per cent for any 
macrovascular complication and 82.2 per cent for any complication (Bach et al., 2014). The cost and 
resource implications of this are substantial. 
 
Type 1 diabetes mellitus 
Due to a chronic autoimmune process involving the development of autoantibodies that mediate 
immune destruction of pancreatic beta-cells, people with T1DM progressively lose pancreatic 
function including the loss of insulin production to the point that they require insulin injections to 
control blood sugar levels (Bluestone et al., 2010). The incidence of T1DM varies among countries, 
and although Australia showed ‘intermediate’ or ‘high’ incidence levels (1990-1999) in the World 
Health Organization (WHO) DIAMOND study (Multinational Project for Childhood Diabetes), the 
AIHW has reported a slightly lower incidence at 11 cases per 100,000 people (2011) and state that 
this has remained stable between 2000 and 2011 (Tuomilehto, 2013, AIHW, 2014b). Genetic factors 
are known to contribute to the development of T1DM, and the incidence increases with age up to 
puberty (DIAMOND Project Group, 2006). There is currently no known way to prevent T1DM. A 
major aim of T1DM prevention research is stopping the destruction of beta cells. However, current 
trials targeting treatment in periods prior to the development of autoimmunity, after autoantibodies 
are found, and after diagnosis, have largely met with no or limited success (Wherrett, 2014, Atkinson 
et al., 2014). In established T1DM, failure to control blood glucose levels with insulin injections 
exposes individuals to an increased risk for microvascular complications affecting small blood vessels 
(retinopathy, nephropathy, and neuropathy) and macrovascular complications affecting larger blood 
vessels (including stroke, acute myocardial infarction) (Atkinson et al., 2014). Intensive insulin 
treatment provided in the long-term Epidemiology of Diabetes Interventions and Complications 
(EDIC) trial demonstrated a significant reduction (58%) in the risk of cardiovascular disease events in 
T1DM. This trial was an extension of the original Diabetes Control and Complications Trial (DCCT) in 
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which treatment was associated with a 35-76 per cent reduction in microvascular complications (The 
Diabetes Control and Complications Trial Research Group, 1993, Nathan, 2014). Intensive insulin 
treatment to control blood glucose levels and optimise metabolic regulation remains the cornerstone 
of T1DM care (Atkinson et al., 2014). 
 
Type 2 diabetes mellitus 
Characterised by insulin resistance, with or without impaired insulin secretion, risk factors for T2DM 
include genetic predisposition, high blood pressure, overweight and obesity, and insufficient physical 
activity (Noble et al., 2011). Prevention of T2DM has been demonstrated in RCTs where intervention 
directly addressed those risk factors that could be modified (e.g. weight gain, blood pressure and 
physical activity) (Knowler et al., 2002, Knowler et al., 2009, Li et al., 2008, Lindstrom et al., 2013, Pan 
et al., 1997, Tuomilehto et al., 2001, Uusitupa et al., 2009). People with T2DM have an increased risk 
for microvascular and macrovascular complications. The landmark randomised United Kingdom 
Prospective Diabetes Study (UKPDS) demonstrated that control of blood glucose levels was 
associated with a significantly reduced risk for microvascular complications in people with newly 
diagnosed T2DM (Stratton et al., 2000). More specifically, the UKPDS established that there is a 
direct relationship between the risk of complication of diabetes and glycaemia over time, each one 
per cent reduction in HbA1c was associated with a 37 per cent reduction in risk for microvascular 
complications (Stratton et al., 2000). A follow-up study for UKPDS found that, after 10 years, blood 
glucose levels were again similar in the intensive management and usual care cohorts, but the 
intervention cohort had a significantly reduced risk of micro- and macrovascular complications 
compared with the control group (Holman et al., 2008). This is known as the ‘legacy effect’, a 
sustained impact due to improvements at the time of treatment even though those improvements 
(e.g. better glucose control) are not maintained (Chalmers and Cooper, 2008). Largely based on these 
findings, blood glucose control has been the cornerstone of T2DM management. However, it is also 
recognised that aiming for good glycaemic control, defined as HbA1c≤53mmol/mol (7%), must be 
balanced against the potential conflict between this and patient priorities depending on their 
circumstances (e.g. limited life expectancy, advanced complications or a history of severe 
hypoglycaemia) (RACGP and Diabetes Australia, 2014-15). This is particularly so among the elderly 
where the benefits of intensive management of HbA1c may be outweighed by the risk of severe 
hypoglycaemia; or where there is potential for dangerous drug interactions because of renal 
impairment or polypharmacy (RACGP and Diabetes Australia, 2014-15). In addition to elevated blood 
glucose levels, the risk of microvascular and macrovascular complications is influenced by changes in 
blood pressure (e.g. systolic blood pressure, SBP) and lipid levels (e.g. Total cholesterol (Tc), Low-
Density-Lipoprotein (LDL) cholesterol). All of these biological markers are referred to as surrogate 
markers for the hard endpoints of microvascular and macrovascular disease. “A surrogate marker is 
measurable, recordable and often changes more rapidly and more sensitively than the hard end 
point in response to interventions”(Weston, 2008, p S6).  
 
Pre-diabetes 
Pre-diabetes (impaired fasting glucose or impaired glucose tolerance) refers to the condition where 
blood glucose levels are above normal but not sufficiently high to be classified as diabetes. Analysis 
of control group patients in the long-term Finnish Diabetes Prevention Study (DPS) projected that 
approximately 50 per cent of people with impaired glucose tolerance will develop diabetes over a 10 
year period when no lifestyle intervention is applied. (Lindström et al.) 
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Gestational diabetes mellitus (GDM) 
Named for the fact that it first occurs during pregnancy, there is currently no internationally 
consistent definition of gestational diabetes mellitus (GDM). However, a recent, renewed call for an 
international consensus statement on diagnosis of GDM suggests that achieving this would “allow 
useful comparisons regarding treatment and longer-term outcomes for this population group” 
(McIntyre et al., 2014). Given that the risk factors for GDM and T2DM are similar, global increases in 
prevalence of T2DM are likely to be mirrored in increases in GDM (McIntyre et al., 2014). For 
Australian GPs, as noted in a recent review of the care of women during and after a pregnancy 
affected by GDM, there are currently three sets of guidelines that are similar (including use of 75g 
oral glucose tolerance test, OGTT, in the first trimester), but not identical and this can impact on 
implementation (Wilkinson et al., 2014). GDM typically disappears when the baby is born, but the 
mother is then at high risk for T2DM over the next 10-15 years (Diabetes Australia, 2012, Bellamy et 
al., 2009). In addition to this, the landmark Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) 
study  established the existence of a continuous relationship between maternal oral glucose 
tolerance test (OGTT) values and adverse outcomes including clinical neonatal hypoglycaemia, 
neonatal hyperinsulinaemia, foetal adiposity, preeclampsia and large-for-gestational-age babies 
(HAPO Study Cooperative Research Group, 2002). Although GDM is a strong predictor of T2DM, 
prevention during a pregnancy involves a major focus on tightly controlled blood glucose levels 
rather than on the weight loss goals targeted among non-pregnant individuals at risk for T2DM 
(Wilkinson et al., 2014).  
 
Primary care based prevention and management of diabetes 
General practitioners (GPs) have a major role to play in diabetes care (Thepwongsa et al., 2014). For 
most people, GPs are the first contact point in the Australian health care system, and in 2009-10 
approximately 83 per cent of the Australian population claimed at least one GP service from 
Medicare (Britt et al., 2013). Approximately 10 per cent of all patients attending a GP in Australia 
have diabetes (Britt et al., 2013). Based on the Better Evaluation and Care of Health (BEACH) study, it 
was estimated that patients with T2DM visited a GP an average of eight times per year in 2013, with 
almost half of these visits being to manage their diabetes (Britt et al., 2013). Despite this, only minor 
improvements have been reported across Australia since 2007 for average blood glucose levels 
(Michaelides and Daja, 2010, Diabetes Australia, 2012). Further, a small survey of 78 Australian GPs 
in 2010 found that the overall application rate of the T2DM screening tool, AUSDRISK, in general 
practice is low (Wong et al., 2011). In a review of the role of Australian PHC in the prevention of 
chronic disease, Harris and Lloyd (2012) identified evidence for gaps in preventive care in practice, 
including under-utilisation of practice nurses, allied health providers and group programmes. 
 
Policy context 
Obesity predisposes people to T2DM and in the decade between 2003-04 and 2012-13, the 
prevalence of overweight/obese adults visiting GPs increased from 57 per cent to 61 per cent (Britt 
et al., 2013). Australia is one of very few countries to have had a national incentivised diabetes 
prevention policy including referral to Lifestyle Modification Programmes to reduce weight. The 
current prevention arrangement includes incentives for screening of people aged 40-49 years (MBS 
items 701, 703, 705, 707) and referral to community-based physical activity and healthy eating 
programmes. For four years from 2009/10, many such programmes received funding grants from a 
pool of $71.8 million made available by the Australian Government under the Healthy Communities 
Initiative (HCI) (Noble et al., 2011, Australian Government Department of Health). With an ever-
increasing number of people presenting to general practice for diabetes care, it is essential that the 
delivery of care is both adequate and effective. For people with diagnosed diabetes, management is 
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supported through the practice incentives programme (PIP) orientated around completion of the 
annual cycle of care (Australian Government Department of Health, 2014). However, in 2009-10 
Medicare claims showed a relatively low uptake, with only 18 per cent of Australians with diabetes 
completing an annual cycle of care (AIHW, 2013).  
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Aim 
This Policy Issue Review aimed to identify key elements of effective programmes of diabetes 
prevention and care, and provide an overview of selected programmes currently implemented or 
being trialled in general practice with published outcomes related to primary and/or secondary 
prevention. Where possible, distinction between programmes will be made on the basis of diabetes 
type: T1DM, T2DM, GDM; and where possible on the basis of target population: e.g. mainstream, 
Indigenous, high risk.  
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Methods 
A thorough (though not systematic) review of Australian and international literature was undertaken 
to search academic and grey literature sources including, but not restricted to: PubMed, Trove, 
Google Scholar, Scopus, PHCRIS PHC search filter; and publicly accessible websites of relevant 
companies and organisations including Diabetes Australia, Royal Australian College of General 
Practitioners, Australian Institute of Health and Welfare. 
 
Keywords applied in the searches included the following terms (and synonyms or derivatives of the 
terms): diabetes; prevention; management; primary health; primary care; general practice; 
community health; family practice; family medicine. Due to the limited timeframe for this review (8 
weeks), searches and critical appraisal of the literature were pragmatic rather than systematic. In 
order to obtain the most relevant material quickly, the combinations of search terms varied across 
different databases. Therefore, replication of this review may result in a different literature base. 
 
For the purposes of this review: 
 Primary prevention is defined as prevention of diabetes onset 
 Secondary prevention is defined as reducing the rate of diabetes progression or reducing the 
development of diabetes-related complications in those with diagnosed diabetes. 
 
Searches were restricted to English language, and Australia, New Zealand, UK and Canada; and the 
search period restricted to articles published in the past five years (i.e. since 2008), although older 
articles cited in newer articles may be included as appropriate. Only programmes delivered by 
general practice and with published outcomes data are included in this review. Articles that included 
high-risk populations, including Aboriginal and Torres Strait Islander peoples, people with disabilities 
and multimorbidities, those living in rural and remote areas, culturally and linguistically diverse 
populations or those with low socioeconomic status are included, but due to time and resource 
constraints, specific searches for different high-risk groups was not undertaken. 
 
A total of 2,470 peer reviewed articles were captured through the database searches, and this was 
added to by ‘snowballing’ and grey literature searches on the internet. 
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Findings 
Primary prevention programmes for diabetes in general 
practice 
Type 1 diabetes 
No trial has successfully demonstrated prevention of T1DM (Australasian Paediatric Endocrine Group 
and the Australian Diabetes Society, 2011). Australian guidelines for T1DM in children and 
adolescents currently recommend that “in the absence of a proven intervention to prevent 
progression to T1DM, screening or intervention in the preclinical phase should be confined to 
defined clinical studies” (Australasian Paediatric Endocrine Group and the Australian Diabetes 
Society, 2011).  
 
However, there have been a number of trials (and some are underway) aimed at preserving 
pancreatic function to prevent or delay onset of T1DM (Wherrett, 2014, Skyler, 2013). Efforts to 
prevent or cure T1DM are generally via large collaborative networks, with rigorous mechanistic 
assays and uniform protocols (Atkinson et al., 2014). Australian researchers are currently involved in 
at least one collaborative primary prevention trial for T1DM: the international TrialNet collaboration, 
which comprises a series of studies to determine whether new treatments (e.g. use of oral insulin) 
can delay or prevent the onset of T1DM in those at risk (TrialNet, 2014). 
 
Type 2 diabetes 
Primary prevention of T2DM, defined as prevention of diabetes onset, has been demonstrated under 
trial conditions through lifestyle modifications, pharmacotherapy, and surgical approaches to reduce 
obesity (Colagiuri et al., 2009). Current Australian guidelines (published in 2009) state that 
progression to T2DM can be prevented; Evidence level I (Colagiuri et al., 2009). Three landmark trials 
have contributed to this evidence: the Finnish Diabetes Prevention Study (DPS), the US-based 
Diabetes Prevention Programme (DPP), and the Da-Qing Study in China (Knowler et al., 2002, 
Knowler et al., 2009, Li et al., 2008, Lindstrom et al., 2013, Pan et al., 1997, Tuomilehto et al., 2001, 
Uusitupa et al., 2009). Lifestyle and dietary strategies have also been employed among women with 
GDM or at risk for developing GDM and, although there is a need for better-designed studies, there 
appears to be some evidence of benefit (Chasan-Taber, 2014, Oostdam et al., 2011). 
 
Evidence base of Type 2 diabetes prevention programmes 
In the DPS, overweight subjects with impaired glucose tolerance (IGT) were randomised to either a 
usual care control group or an intensive lifestyle intervention (Uusitupa et al., 2009, Lindstrom et al., 
2013, Lindstrom et al., 2003). In the first year, mean weight loss with intervention was approximately 
five per cent (4.5kg), reducing to four per cent after three years. Based on observed T2DM incidence 
after three years, the risk of T2DM was reduced by 58 per cent in the intervention group compared 
to controls; and it was also noted that high-risk individuals did not develop diabetes during the initial 
trial period if they reached at least four of five predefined lifestyle targets: 
 weight loss greater than five per cent 
 intake of fat less than 30 per cent of energy 
 intake of saturated fats less than 10 per cent of energy 
 increase dietary fibre to equal or greater than 15g/1,000 kcal 
 increase physical activity to at least 4h/week. 
 
A post-intervention follow-up study demonstrated that after three years the incidence rate per 100 
person-years was 8.4 in participants who did not achieve any of the goals compared to 2.0 among 
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those who achieved at least four, and over seven years the relative reduction in diabetes incidence 
for the intervention group was 43 per cent (Lindström et al., 2006). 
 
In the US population-based DPP study, a randomised trial design was used to compare lifestyle 
intervention versus placebo or pharmacotherapy with the hypoglycaemic agent metformin among 
people with IGT (Knowler et al., 2002, Knowler et al., 2009). The aim of the intervention was to 
achieve and maintain seven per cent weight loss and 150 minutes or more per week of moderate-
intensity physical activity (Knowler et al., 2009). The lifestyle intervention was more effective than 
metformin, leading to a mean weight reduction of almost six kg (5.9%) after 2.8 years, compared to 
2.1kg with metformin over the same period (after 24 weeks the weight reductions were 6.8kg and 
2.5kg respectively) (Knowler et al., 2002, Knowler et al., 2009, Tuomilehto et al., 2011). After 2.8 
years, the rate of T2DM in the DPP was 11.0, 7.8, and 4.8 cases per 100-person years in the placebo, 
metformin, and lifestyle groups respectively. An analysis of diabetes incidence after three years of 
follow-up demonstrated that, after adjustment for diet and activity, for every kilogram of weight loss 
there was a 16 per cent reduction in risk (Hamman et al., 2006). 
 
The Da Qing Study examined the effects of a 6-year diet and exercise intervention in Chinese subjects 
with IGT, and found that diet alone was associated with a 31 per cent reduction in the risk of 
developing T2DM compared to a 46 per cent reduction with exercise alone (combining exercise plus 
diet did not affect outcomes, 42 per cent reduction) (Li et al., 2008, Pan et al., 1997). The long-term 
benefits of lifestyle interventions suggests a ‘legacy’ or carry-over effect with a risk reduction of 43 
per cent after 20 years follow-up in the Da-Qing study; and similarly 43 per cent in the DPS after 
seven years; and 34 percent in the DPP after ten years (Tuomilehto et al., 2011).  
 
In a systematic review of nine RCTs, including both the DPP and DPS, the positive impact of lifestyle 
interventions on reducing the incidence of T2DM was confirmed (Gillett et al., 2012). However, it was 
also noted that many participants did not succeed, and others succeeded in the first six months but 
not in the longer term (Gillett et al., 2012). A systematic review and meta-analysis of 71 studies 
aimed at prevention of T2DM found that overall study quality was poor, but the evidence indicated 
significant efficacy for antidiabetic drugs, physical activity with diet, diet alone, physical activity or 
education, antihypertensive drugs, and lipid-lowering drugs, but higher effectiveness of bariatric 
surgery among the morbidly obese (Merlotti et al., 2014). These outcomes suggest that there may be 
several strategies for prevention of T2DM (Merlotti et al., 2014). The need for individualised care in 
optimising management of diagnosed diabetes is widely recognised, and the availability of different 
diabetes prevention strategies would enable a similar approach to prevention.  
 
With respect to GDM, a meta-analysis of prevention programmes published between 1980 and 
March 2011 identified 19 eligible RCTs and, although most of the studies were considered to be of 
very low quality, it was concluded that dietary counselling, advice on a low glycaemic index (LGI) diet, 
or an exercise programme could be beneficial and probiotics might be promising (Oostdam et al., 
2011). Similarly, a recent Cochrane review found insufficient evidence to determine if screening for 
GDM, or what types of screening, can improve maternal and infant health outcomes (Tieu et al., 
2014). 
 
Mediterranean diet 
Although we were unable to identify any diabetes prevention programmes within PHC specifically 
recommending use of the Mediterranean diet (MeDiet) there is consistent, good quality evidence 
documenting its association with a significant reduction in the incidence of T2DM (Salas-Salvadó et 
al., 2011, Kastorini et al., 2011, Martínez-González et al., 2008, Esposito et al., 2010, Itsiopoulos et al., 
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2011, Salas-Salvadó et al., 2014, Koloverou et al., 2014). Composition of the MeDiet varies but is 
based primarily on high consumption of vegetables, legumes, grains, fruits, nuts, and olive oil, 
moderate consumption of fish and wine, and low consumption of white meat, eggs and whole-fat 
dairy products, and limited consumption of red meat (Bach-Faig et al., 2011). Of note, a recent, good 
quality meta-analysis, which included one clinical trial and nine prospective studies accounting for 
almost 137 thousand participants, found a significant 23 per cent reduction in the risk of developing 
T2DM for those most adherent to a MeDiet compared to the least adherent (Koloverou et al., 2014). 
This is less than the 52 per cent reduction demonstrated in the only RCT of MeDiet and T2DM 
prevention, but likely reflects heterogeneity in study setting, MeDiet content, and participant 
characteristics across the studies. Hence is potentially more relevant to expected impact with ‘real-
world’ implementation (Salas-Salvadó et al., 2011). Currently RACGP guidelines for T2DM 
recommend the MeDiet for those at high risk for CVD (RACGP and Diabetes Australia, 2014-15). 
Although weight loss is relatively minor with the MeDiet (<1kg in the RCT), the diet is well tolerated 
and adherence is reportedly high. Moreover, the significant reductions in development of T2DM 
were also achieved in the absence of energy restriction or promotion of physical activity (Salas-
Salvadó et al., 2011). Further investigation of the MeDiet is required with respect to T2DM 
prevention, including the value of combination with increased physical activity and the relative 
contributions of different food types, as well as the potential benefit across the age and risk 
spectrum. However, there is currently sufficient evidence to recommend this as an alternative 
dietary plan for those at risk for T2DM, particularly for those less adherent to the low-fat diets 
prescribed in the DPS and DPP based programs.  
 
Risk assessment for T2DM 
Use of the ten item Australian Diabetes Risk assessment tool (AUSDRISK) is recommended in 
Australian T2DM prevention guidelines to identify those at high risk (Colagiuri et al., 2009, RACGP, 
2012). The risk factors included in the AUSDRISK tool are: age, gender, country of birth, family history 
of diabetes, history of high blood glucose, hypertension, smoking status, fruit and vegetable intake, 
physical activity levels and waist circumference (Wong et al., 2011, Chen et al., 2010). A score of 12 
or more is defined as high risk in the RACGP clinical guidelines for preventive activities in general 
practice, although a score of 15 or more is used in the 2009 National Evidence Based guideline 
(RACGP, 2012, Colagiuri et al., 2009). AUSDRISK was not designed to identify IGT. The recommended 
action for those identified as being at high risk for T2DM is lifestyle modification interventions 
implemented at the level of routine clinical practice (RACGP, 2012, Colagiuri et al., 2009). 
 
In contrast, despite identifying 145 published risk prediction models and scores for T2DM, Noble et 
al. (2011) noted that, internationally, there is limited evidence demonstrating the application of 
these models as part of a formal health policy. Australia’s scheme to pay GPs for measuring risk of 
diabetes in adults was cited as one exception to this finding (Noble et al., 2011). Noble et al. (2011) 
included the Australian T2DM risk assessment tool, AUSDRISK, in a list of seven validated diabetes 
risk scores judged to be the most promising for use in clinical or public health practice. 
 
Real-world implementation of primary prevention of T2DM 
Translating trial-based outcomes to real-world settings is complicated by greater patient diversity 
and limited resources. The challenge is to identify those at greatest risk, and to deliver and achieve 
engagement with interventions to sustain lifestyle changes primarily leading to weight loss and 
increased physical activity (Johnson et al., 2013). A high quality, systematic review of 28 US-based 
translation studies implementing the DPP in real-world settings found that clinically significant 
weight loss (by 4-5% of body weight) was achieved over nine months of follow-up (Ali et al., 2012). 
However, this finding should be interpreted with caution as the quality of many of the included 
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studies was poor. Ali et al. (2012) also noted that comparable weight change was observed in studies 
using medical and allied health professionals versus lay community educators, and that programme 
costs were driven by the cost of glucose-based eligibility testing and salaries for intervention staff (Ali 
et al., 2012). Although the poor quality of studies warrants caution when interpreting these results, 
this suggests that use of lay community educators following GP referral could potentially reduce the 
cost of lifestyle intervention without compromising intervention efficacy. 
 
Expanding on the study of Ali et al. (2012), a review of community-based interventions found that 
weight loss after 12 months was about the same as that achieved in the later years of the major trials 
(approximately 4.2kg) (Kahn and Davidson, 2014). Specifically, in the DPP, the mean reported weight 
loss after 12 months was 7kg with lifestyle intervention; but after three years the difference 
compared to baseline had declined to approximately 4kg, which was more consistent with the weight 
loss reported after 12 months in community-based interventions (Knowler et al., 2009). In the US, 
based on their findings of reduced impact in ‘real-world’ studies, Kahn and Davidson (2014) 
questioned the use of public funds for national prevention initiatives that used lifestyle modification 
to prevent diabetes; suggesting instead that there may be more benefit to be gained from national 
policies designed to reduce our overall consumption of food. Similarly, a systematic review and 
meta-analysis of 12 mostly good quality studies that evaluated diabetes risk and physical 
activity/nutrition interventions in routine clinical practice found that translation to routine practice 
leads to significant, but modest, weight loss but no significant change in metabolic indicators of 
diabetes risk (FPG or OGTT) (Cardona-Morrell et al., 2010). At 12 months, mean weight reduction was 
1.82kg greater with intervention compared to controls, and it was noted that loss-to-follow-up varied 
greatly between five and 57 percent (Cardona-Morrell et al., 2010). 
 
The recently reported three year follow-up of the Health Information, Nutrition and Exercise (SHINE) 
implementation of a DPP-based programme for adults with metabolic syndrome, warrants mention 
here because it was not included in those meta-analyses and it was delivered in the PHC setting (Trief 
et al., 2014). The SHINE intervention was delivered over two years via telephone either individually 
(IC) or in groups via conference call (CC) with all participants sending logged diet/activity/weight to 
educators on a monthly basis. There was no intervention in the third year. Educators (primary care 
practice staff) and coaches (registered dietitians) delivered the intervention weekly for the first five 
weeks and thereafter on a monthly basis, with educators and coaches alternating. At the three-year 
follow-up, mean weight loss was similar to outcomes at year two and significant at -6.4kg for CC 
versus -2.35kg for IC (Table 1). This translated into approximately 51 per cent of CC participants and 
29 per cent of IC achieving weight loss of at least five per cent over the three year period. 
Interestingly, with respect to proportion achieving at least five per cent weight reduction, there was 
no difference between study completers and non-completers at three years for the CC group (51% vs 
50%, respectively) but a significant difference for the IC group (37.8% vs 5.6%, respectively). Although 
both groups recorded improvement in HDL cholesterol, only IC participants experienced significant 
increases in blood pressure over the three year period, and there was no mention of any impact on 
physical activity or diet for either group.  
 
Selected examples of primary prevention programmes for T2DM relevant to the Australian setting 
and reporting outcomes data 
All of the primary prevention programmes for T2DM, which were identified in the current review as 
being relevant to the Australian setting, targeted weight loss and physical activity as described in the 
DPS programme. Specifically, programmes targeted weight loss of five per cent or more of body 
weight, as well as increase in physical activity to four hours or more per week, and improved diet. 
Screening for T2DM was based on application of the AUSDRISK tool in Australian lifestyle 
modification programmes. However, it is interesting to note that the Australian Primary Care 
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Collaborative Programme (APCCP)i reported in February 2014 that just two per cent of eligible 
patients were screened with the AUSDRISK tool (Australian Primary Care Collaborative, 2014). In the 
following section, we provide an overview of key outcomes from relevant primary prevention 
programmes reporting outcomes data, and in Table 1 these are highlighted and compared to the DPP 
and DPS. More detailed summaries are provided in the Appendices. 
 
Two high-profile, group-based, diabetes prevention programmes, Life!Taking action in diabetes 
(Life!) and the Sydney Diabetes Prevention Programme (SDPP), were trialled in the Australian clinical 
setting and have met with similar levels of moderate success (Colagiuri et al., 2010, Davis-Lameloise 
et al., 2013, Dunbar et al., 2014, Laws et al., 2012, Vita et al., 2013, Cardona-Morrell, 2011). 
Approximately 25 per cent of participants completing the Life! and SDPP programmes recorded 
weight loss greater than five per cent, but only Life! participants reported improved physical activity 
(Table 1). Mean weight loss was also very similar between programmes at 2-2.4kg (<5%) for 
completers, although for those attending five Life! sessions (completers and non-completers), mean 
weight loss was less at 1.4kg (Dunbar et al., 2014). Reporting outcomes only for completers (as 
opposed to Intention-To-Treat (ITT) analyses including all participants enrolled at baseline) has been 
criticised because programme costs are also incurred for those who do not complete and this can 
impact on programme scalability (McCombie et al., 2012). Based on reference to the DPP and DPS 
reported reductions in diabetes incidence, it was proposed that the almost three per cent mean 
weight loss in the Life! study might correspond to a 21-32 per cent reduction in diabetes incidence 
(Dunbar et al., 2014). 
 
In both Life! and SDPP, people at high risk for T2DM were identified using the AUSDRISK tool and a 
cut off score of 15ii or more (DPP and DPS entry was based on confirmed IGT). However, there were 
also important differences between the Australian programmes: entry into Life! was via multiple 
entry points (GP referral, Life! Provider and facilitator referral, workplace and social media-based 
recruitment); entry into SDPP was via GP referral only. This could potentially result in participants 
with lower risk being included in the Life! study. Further, Life! was a motivational programme 
delivered by certified health professionals with input from dietitians and physiotherapists for two 
sessions and working across community sectors including public and private; whereas the SDPP was 
delivered by Lifestyle Officers with scheduled GP consultations at 4 and 12 months, and participants 
were encouraged to attend local community-based lifestyle programmes to help achieve the physical 
activity and dietary goals. In addition, Life! participants were more likely to be socioeconomically 
disadvantaged than SDPP participants (53% versus 3%). Adaptation of the Life! programme to meet 
the Indigenous community’s needs, and development of the MAGDA programme for women with a 
history of GDM demonstrates the utility of this model in meeting the sometimes very different needs 
and priorities of people with diabetes. However, reporting of outcomes is now required to determine 
the efficacy of these adaptations. 
 
The success of lifestyle intervention is dependent on adherence to the programme and retention of 
participants; and this remains a challenge (Vita et al., 2013). Retention in the complete Life! 
programme was just 37 per cent for attendance at six sessions. However, this was in part due to the 
financial incentive payment structure whereby course providers may not have offered the sixth 
session. In contrast, 78 per cent of participants attended five Life! sessions, and this is similar to the 
82 per cent retention rate in the SDPP. Optimisation of these programmes for those not achieving 
lifestyle targets and to further improve retention is now required, as are economic analyses and long-
term data on diabetes incidence. 
                                                          
i See the secondary prevention section in this review for more information. 
ii The ASUDRISK score for Life! entry has since been reduced to 12 or more. 
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It is important to note that weight loss in the Life! and SDPP were substantially lower than the weight 
loss reported from the DPS and DPP randomised trial studies after 12 months. However, these 
outcomes are comparable to the ‘real-world’ UK based Counterweight lifestyle intervention, see 
Table 1. The Counterweight programme is an evidence- and theory-based intervention for weight 
management delivered through general practice and shown to be highly cost-effective using the NICE 
obesity health economic model in the UK setting (and cost saving in most scenarios modelled) (Laws, 
2004, McQuigg et al., 2008, Trueman et al., 2010). The core Counterweight model involves patient 
attendance at six individual or group sessions over a 3-month period with follow-up at three 
quarterly support visits (Ross and Counterweight project team, 2012, Laws, 2004). Based on an 
evaluation conducted between 2000 and 2005, mean weight loss at 12 months was 2.96 kg among 
attenders, with 45 per cent of participants completing 12 months and 31 per cent meeting the target 
of greater than five per cent weight loss (2008). Approximately one third of participating practices 
were located in socially deprived areas. The Counterweight programme is currently being trialled in 
Australia in both Sydney and Adelaide. 
 
A comparative review of Life! and SDPP highlighted the success of social marketing strategies in the 
former and suggested that limiting prevention programmes to the PHC setting results in limited 
impact (Vita et al., 2013). However, it should be noted that GPs referred approximately one third of 
Life! participants despite differences in incentive payments with GPs receiving $20 for each referral 
and an additional $30 upon completion of the introductory session; compared to programme 
facilitators being paid $400 per participant that they take through the programme (Dunbar et al., 
2014, Lifeprogram, 2014). In contrast, workplace recruitment accounted for less than six per cent of 
referrals, and this outcome was due in part to the difficulty of ensuring an individual’s privacy.  
 
The SDPP encouraged participants to access local community-based lifestyle programmes. In line 
with the Healthy Communities Initiative (HCI), which was funded for four years from 2009/10, a 
number of community-based lifestyle interventions are currently available with or without GP 
referral and generally at no cost. A selection of these are listed in Table 2, but published outcomes 
data were not located for most of them (Australian Government Department of Health). One 
community-based programme with published outcome data is the Healthy Eating Activity and 
Lifestyle (HEAL™) programme, an eight-week programme based on an hour of supervised exercise 
and an hour of healthy lifestyle education each week (Hetherington and Borodzicz, 2013). Based on 
data from more than 1,700 participants over a three year period, at programme end participants 
recorded a mean weight reduction of one kg, a 13 per cent increase in physical activity, a mean 
change in systolic blood pressure (SBP) by -3.1 mmHg, and a programme retention rate of 61 per 
cent. Follow-up data obtained at five months indicated that weight loss and physical activity 
continued to increase, while improvements in healthy eating were maintained. The impact of the 
HEAL intervention on cardiovascular risk factors such as blood pressure is particularly encouraging 
and should prompt further investigation and implementation. It will be of interest to observe 
whether the weight loss at 12 months approaches that reported by Life! and SDPP. 
 
Generating outcome data from all of these programmes and ongoing trials such as Mothers After 
Gestational Diabetes in Australia Diabetes Prevention Programme (MAGDA-DPP) and the 
international PREVention of diabetes through lifestyle Intervention, PREVIEW study, will be very 
important for future funding decisions given evidence of variability in retention rates and the impact 
of intervention on important surrogate markers such as weight loss, physical activity and blood 
pressure. Extrapolation from observed weight loss to changes in T2DM incidence based on DPP and 
DPS findings will be required until sufficient follow-up time has elapsed to report on actual incidence 
of T2DM, but efforts to confirm this with actual incidence data should be encouraged.  
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Cost-effectiveness of diabetes prevention programmes 
In an extensive and detailed systematic review of literature published before January 2012, Gillett et 
al. (2012) concluded that it is difficult to reach a definitive conclusion regarding the cost-
effectiveness of lifestyle interventions for the prevention of diabetes. Their conclusion was based on 
conflicting results from economic modelling studies. Several studies used Markov-type economic 
modelling to predict that lifestyle interventions that delayed diabetes “would provide good value for 
money” (p 71). However, using a “more complex model not widely used in health-care decision 
modelling” (Archimedes Diabetes Model), and outcomes from the DPP, predictions indicated that 
lifestyle interventions to prevent diabetes were not cost-effective. Although Gillett et al. (2012) 
noted that estimated cost-effectiveness was particularly sensitive to changes in intervention cost and 
participant adherence (and hence maintenance of intervention effectiveness), they also found 
agreement between the different models with respect to the significant impact of maintenance of 
lifestyle changes and weight loss on the risk of developing diabetes and its associated complications. 
More recently, an extensive review of 46 studies modelling the economics of T2DM prevention 
concluded that there is a need to develop more flexible models that incorporate multivariate risk 
equations for T2DM, and include diabetes-related complications and co-morbidities (Watson et al., 
2014). This is an area in need of further development. 
 
Nevertheless, two cost-effectiveness modelling studies have been reported where ‘real-life’ 
scenarios were created to more closely reflect likely events in routine care (Gillett et al., 2012, 
Palmer and Tucker, 2012). That is, people not adhering to the programme were switched to 
metformin pharmacotherapy after 12 months. This approach addresses criticism of programme 
promotion based only on data from ‘completers’, since those who discontinue also generate costs 
(McCombie et al., 2012). Based on this approach, it was predicted that in the Australian and UK 
settings, lifestyle intervention strategy would be at least cost-effective and potentially cost saving in 
certain scenarios (Gillett et al., 2012, Palmer and Tucker, 2012). However, although incorporating 
treatment changes and any associated side-effects is likely to more closely reflect ‘real-world’ 
scenarios, use of outcome data from RCTs (e.g. weight loss as reported in the DPP or DPS), may 
overestimate the impact of treatment in a clinical setting as discussed above; and therefore the 
projected cost-effectiveness may be overestimated. Thus, it is important that economic analyses 
include (and publish) extensive and rigorous sensitivity analyses that project outcomes based on 
uncertainty in key parameters (e.g. use of 95% confidence limits, where possible); and where 
evidence exists, they should reflect ‘real-world’ expectations particularly with respect to weight loss.  
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Table 1 Summary of reported outcomes for selected Type 2 diabetes prevention programmes 
Programme 
 
Risk assessment n Clinical impact on surrogate markers at 12 months^ Retention 
rate (%) 
Impact on incidence 
of diabetes 
Finnish Diabetes 
prevention study 
(DPS) (Uusitupa et 
al., 2009, Lindstrom 
et al., 2013, 
Lindstrom et al., 
2003) 
IGT 522 Mean weight loss 4.5kg (5.2%) 
 
At three years, approximately 46% achieved a 5% or greater 
weight loss goal 
14% achieved four or five goals (vs 6% for control), 10% did not 
achieve any of the goals(vs 27% for control) 
NR 
 
 
58% reduction 
US Diabetes 
Prevention study 
(DPP) (Knowler et 
al., 2002, Knowler et 
al., 2009) 
IGT 3,819 Mean weight loss 6.8kg  (7.2%) with lifestyle 
Mean weight loss 2.5kg  (7.2%) with metformin 
 
50% achieved 7% or greater weight loss goal at 24 weeks 
74% achieved physical activity goal at 24 weeks 
NR 58% reduction with 
lifestyle 
31% reduction with 
metformin 
Life!Taking action in 
diabetes 
(Dunbar et al., 2014) 
AUSDRISK 6,632 Mean weight loss 2.4kg (2.8%) for study completers 
Moderate change in physical activity (baseline 11.3% vs 17.6% 
for study completers) 
Moderate change in diet (baseline 31% vs 65.1% for study 
completers) 
37* NR 
Sydney Diabetes 
Prevention 
Programme (SDPP)# 
(Cardona-Morrell, 
2011) 
AUSDRISK 1,250 Mean weight loss 2kg , approximately 2% (1.8kg at two years, 
and 2kg at three years) 
No change in physical activity 
 
Approximately 24% of study completers achieved a 5% weight 
loss goal  
Only 11.5% achieved four goals and 1% five goals, 20% did not 
achieve any of the goals 
82.3 NR 
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Programme 
 
Risk assessment n Clinical impact on surrogate markers at 12 months^ Retention 
rate (%) 
Impact on incidence 
of diabetes 
Healthy Eating 
Activity and Lifestyle 
(HEAL™) 
(Hetherington and 
Borodzicz, 2013) 
GP referral  1,500 Weight loss 1.0kg after 2 months 
Physical activity increase by 13% after 2 months 
SBP decrease by 2% (3.1mmHg) 
Also Improved diet, 6-min walk, reduced sitting 
61 NR 
Counterweight 
(2008, Laws, 2004, 
Ross and 
Counterweight 
project team, 2012) 
GP assessment 
and BMI≥30 
kg/m
2
 or ≥28 
kg/m
2
 with co- 
morbidity 
1,906 Mean weight loss for completers (n=1,419) at 12 months was 
2.96kg (3%) and at 24 months 2.3kg (n=825) 
 
Approximately 31% of study completers (14% of all patients) 
achieved a 5% weight loss goal at 24 months 
45 NR 
Building on Existing 
tools to Improve 
chronic Disease 
Prevention and 
Screening in Family 
Practice (BETTER) 
(Grunfeld et al., 
2013) 
No specific risk 
calculator but 
screening 
includes blood 
pressure, lipid 
levels, waist 
circumference, 
BMI assessment. 
 
789 Referral for weight control increased (51.4% vs 62.2%)
§
 
Physical activity >90min/week increased (49.7% vs 52.2%)
§
  
Healthy diet score increased (8.2% vs 9.6%)
§
 
Referral for nutrition counselling increased (8.2% vs 9.6%)
§
 
 
NA NR 
 
Support, Health 
Information, 
Nutrition and 
Exercise (SHINE) 
(Trief et al., 2014) 
Metabolic 
syndrome based 
on IDF criteria 
and BMI≥30 
kg/m
2 
257 Mean weight loss for individual call based intervention (IC) -
2.35 kg; for group call based intervention (CC) -6.44 kgβ
 
Proportion achieved a 5% or greater weight loss goal: 28.6% 
(IC) and 50.7% (CC) β 
HDL cholesterol  approximately +2.84 mg/dL for IC, +5.47 for 
CC. 
90 NR 
IGT=Impaired glucose tolerance;NR= Not Reported; NA= Not applicable; GP=General Practitioner; ^ based on Intention-To-Treat cohort unless otherwise indicated; 
§
percent 
improvement for prevention practitioner group compared to control group; *Retention rate potentially biased because this is based on attending six sessions, but in some 
cases the sixth session was not offered; § based on control and prevention practitioner comparison only; ß outcomes at 36 months (1 year after last intervention session). 
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Table 2 Selected community based Type 2 diabetes prevention and lifestyle modification programmes currently implemented but without published 
outcomes data 
Programme  Availability Overview Publications and/or website 
Active measures WA A free, 16-week community-based weight loss programme with self- or GP- 
referral. Based on an exercise programme and dietary education by a dietitian 
including review (0, 3, 6 months), the aim is to gradually improve fitness levels and 
reduce weight. 
http://www.baml.com.au/health-
professional/chronic-disease-hp/ac/ 
Beat it – Physical 
activity program 
NSW, QLD, SA, 
TAS, VIC, WA 
A 10-12 week physical activity and education programme including healthy eating 
and lifestyle advice. Aimed to assist with increasing physical activity levels and 
improving healthy lifestyle behaviours to prevent or manage diabetes and other 
chronic conditions in a safe and supportive environment; and to ensure 
participants are competent to exercise independently following programme 
completion. 
http://www.health.gov.au/internet/h
ealthyactive/publishing.nsf/Content/
healthy-comm-lgag-att_c-
toc~healthy-comm-lgag-att_c-beatit 
Lift for Life ACT, NSW, VIC, 
WA, QLD, NT, 
SA  
Lift for Life is a unique resistance training programme designed for adults with (or 
at risk of developing) T2DM and other chronic conditions. Delivered in 3 eight-
week programmes of up to 12 people attending 2-3 sessions per week. Referral 
forms available for GP use. 
http://www.liftforlife.com.au  
Heartmoves ACT, NSW, NT, 
QLD, SA, TAS, 
VIC, WA 
The Heart Foundation’s Heartmoves offers “a gentle physical activity programme 
suitable for anyone who hasn't done any exercise in a while”. It aims to provide a 
friendly atmosphere where people can exercise “at your own pace” 
http://www.heartmoves.org.au/prog
ram 
Heart Foundation 
Walking 
ACT, NSW, NT, 
QLD, SA, TAS, 
VIC, WA 
Free community-based walking groups led by volunteer community members.  http://www.heartfoundation.org.au/
active-
living/walking/Pages/welcome.aspx  
Healthy Lifestyle 
Programme 
WA GP referral is required for this 12-month programme. A Dietician provides advice 
on maintaining a healthy diet. A Diabetes Educator advises clients with T2DM 
about how to manage their condition. An Exercise Physiologist tailors a structured 
exercise routine to suit individual clients’ needs. 
http://www.baml.com.au/health-
professional/chronic-disease-
hp/healthy-lifestyle-program/ 
Lift for Life ACT, NSW, NT, 
QLD, SA, TAS, 
VIC, WA 
An evidence-based resistance training program for people with, or at risk of, 
T2DM or other chronic diseases. It is available to adults of all ages, and Lift for Life 
is licensed to private health and fitness businesses. 
http://www.heartfoundation.org.au/
active-living/walking/walking-
groups/Pages/WA-Walking-
Groups.aspx  
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Secondary prevention programmes for diabetes in general 
practice 
For people with diabetes, the consequences of uncontrolled blood glucose levels, blood pressure and 
lipids are the progressive development of microvascular (including retinopathy, nephropathy and 
neuropathy) and macrovascular (cardiovascular disease including myocardial infarction and stroke) 
complications. In the current review, secondary prevention is defined as any measures initiated to 
reduce the rate of diabetes progression or to reduce the development or further exacerbation of 
diabetes-related complications in those with diagnosed diabetes. Based on the landmark United 
Kingdom Prospective Diabetes Study (UKPDS) for T2DM and the Diabetes Control and Complications 
Trial (DCCT) for T1DM, it has been established that control of blood glucose and blood pressure can 
significantly reduce the incidence of diabetes-related complications (Nathan, 2014, Stratton et al., 
2000, The Diabetes Control and Complications Trial Research Group, 1993). Therefore, an important 
aim of diabetes management programmes for those with diagnosed diabetes is to reduce the risk of 
complications or further exacerbation of existing complications by controlling these modifiable risk 
factors. Insulin treatment is essential in T1DM and management of diet and insulin dose is a central 
part of effective control. Although early management strategies for T2DM focus on lifestyle and 
dietary changes, pharmacotherapy is also a key element of treatment (Furler et al., 2013). The 
requirement for a broader, more inclusive management programme that incorporates all of these 
elements and addresses broader patient-centred needs, such as education and self-management 
skills, is recognised in diabetes management guidelines (RACGP and Diabetes Australia, 2014-15, 
Colagiuri et al., 2009). For patients with T2DM across the spectrum, structured care programmes that 
are easy to implement, are well-supported and meet the needs of the individual are required (RACGP 
and Diabetes Australia, 2014-15). These programmes bring together healthcare teams, evidence-
based guidelines, useful support tools and good systems to support patients throughout their 
journey. 
 
According to the latest Royal Australian College for General Practitioners (RACGP) guidelines for 
T2DM, the Chronic Care Model (CCM), developed by the MacColl Institute, identifies the 
fundamental elements of a healthcare system that supports high-quality chronic disease care (RACGP 
and Diabetes Australia, 2014-15): 
 health system (organisation and mechanisms) 
 delivery system design 
 decision support 
 clinical information systems 
 self-management support 
 the community. 
 
Key elements of diabetes management programmes identified in systematic 
reviews 
Numerous diabetes management and quality improvement programmes have evolved, and a recent 
meta-analysis of 48 RCTs highlights key aspects of published quality improvement strategies for 
diabetes that positively impact on patient-level surrogate outcomes of glucose levels, blood pressure, 
and lipid levels that, in turn, are known to influence the risk for diabetes-related complications (see 
Table 3) (Tricco et al., 2012). The five programme features associated with chronic disease 
management (CDM)-related reductions in HbA1c, LDL, SBP, and DBP were: 
 Promotion of self-management. Established goals or a written self-management plan, provision 
of equipment (e.g. home glucose meters) or access to resources (e.g. system for electronically 
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transmitting home glucose measurements and receiving insulin dose changes based on those 
data) to promote self-management. 
 Team changes. Changes to the structure or organisation of the primary health care teams (e.g. 
additional members, multidisciplinary teams, expansion or revision of professional roles) 
 Patient education. Interventions designed to promote greater understanding of the disorder or 
to teach specific prevention or treatment strategies. 
 Case management. Any system for coordinating diagnosis, treatment, or routine management of 
patients by a person or multidisciplinary team in collaboration with, or supplementary to, the 
primary-care clinician. 
 Facilitated relay of information to primary clinician. Clinical information collected from patients 
and transmitted to clinicians by means other than the existing medical record (e.g. pharmacist 
issued structured diaries for patients to record self-monitored glucose values or web-based 
methods for patients to provide self-care data, which were then taken to review with primary 
care physician)iii 
 
Although 49 per cent of the studies included in Tricco et al.’s (2012) meta-analysis were US-based, an 
independent review of systematic reviews investigating programmes for improved quality of care for 
persons with diabetes concurred with these outcomes (Worswick et al., 2013). More specifically, 
based on 50 high quality reviews, Worswick et al. found evidence for the importance of patient 
education, team changes, and telemedicine interventions for improving glucose control. Strong 
evidence was also found for a positive role of team change on blood pressure and cholesterol levels. 
However, there was insufficient evidence to determine the role of organisational changes such as 
general practice versus hospital care, or the impact of shared decision-making on glycaemic control 
(Worswick et al., 2013).  
 
Furthermore, in a survey of 38 Primary Care networks in Alberta, Canada, Campbell et al. (2013) 
found that the two most commonly used CDM strategies for patients with diabetes were team 
changes and patient education, despite the fact that team changes were among the most resource-
intensive strategies. It was also found that many primary care networks in Alberta employ several 
CDM strategies concurrently in the management of patients with diabetes, likely reflecting the 
diversity of patients from newly diagnosed through to those with more advanced disease and 
complications.  
 
These more recent findings are in line with an earlier review of CDM in primary care where the 
interventions most likely to be effective in the context of Australian primary care were self-
management support through education and training of GPs and practice nurses and through linkage 
to multidisciplinary team support (Dennis et al., 2008).  
 
Despite all of this, a recent review of diabetes primary care workforce models in Australia, was 
prompted by the “inconsistent support for teamwork care models and a lack of enhanced clinical 
inter-professional education and/or training opportunities” (Schofield et al., 2014, p 1). Although 14 
studies primarily focused on secondary prevention or diabetes management were identified in that 
review, Schofield et al. concluded that there was a general lack of rigour, and the majority of studies 
risked the introduction of bias. Studies offering coordinated diabetes treatment rated poorly, 
achieving only IV or V on the NHMRC framework scale for assessing the level of evidence. According 
to Schofield et al. (2014), there is a need for more rigorous research to assess whether programmes 
                                                          
iii If the results of routine visits with a pharmacist were sent in a letter to the primary-care physician, the use of routine visits with a 
pharmacist would count as a “team” change but the intervention would not also be counted as “facilitated relay”. 
Primary Health Care Research & Information Service 
phcris.org.au 
The role of primary health care in primary and secondary prevention of diabetes - 23 - 
are effective in producing improved health outcomes and whether they represent better value for 
money than current practice.  
 
Table 3 Post-intervention reductions in biological markers associated with specific features of 
diabetes management programmes  
Programme feature Reduction in 
HbA1c (%) 
Reduction in 
LDL mmol/l 
Reduction in 
SBP(mmHg) 
Reduction in 
DBP(mmHg) 
Promotion of self-
management 
0.57 0.18 3.69 1.89 
Team changes 0.57 0.17 4.32 1.75 
Case management 0.50 0.11 4.62 0.93 
Patient education 0.48 0.14 4.02 2.25 
Facilitated relay 0.46 0.16 4.31 0.82 
Electronic patient register 0.42 0.09 3.35 0.78 
Patient reminders 0.39 0.01 1.82 0.76 
Audit and feedback 0.26 0.03 2.52 0.68 
Clinician education 0.19 0.11 2.56 1.13 
Clinician reminders 0.16 0.14 0.65 1.11 
Financial incentives 0.10 NR 2.00 none 
Continuous quality 
improvements 
none none 1.00 NR 
Based on Tricco et al. (2012). For a full description of programme feature definitions see Appendices. 
NR= Not Reported 
 
Monitoring diabetes management in primary care 
Monitoring general practice management of diabetes in Australia has been a difficult task due to the 
lack of national level reporting. Current data sources are often limited by the type of data collected, 
cohort size, or relevance of the data to the general diabetes population (Erny-Albrecht and Bywood, 
2014). Use of the Pen Computer Systems Clinical Auditing Tool (PCS CAT) auditing tool may represent 
an approach that could be widely implemented to generate the information required to monitor 
diabetes prevalence; and patient management outcomes such as completion of Annual cycle of Care 
(ACC), HbA1c, blood pressure, uptake of preventive health activities offered through the Medicare 
benefits scheme and so forth (Ghosh et al., 2013, Ghosh et al., 2014). Recent pilot studies have 
demonstrated use of the PCS CAT system to monitor chronic disease prevalence and its associated 
risk factors among general practice attendees and at a local level (Ghosh et al., 2013, Ghosh et al., 
2014). In addition to promoting the use of the AUSDRISK Tool to identify people at risk for T2DM, the 
Life! diabetes prevention programme coordinators also highlight the value of using PCS CAT to assist 
with systematic diabetes prevention and management (Life! program, 2014). 
 
Examples of diabetes management programmes relevant to the Australian 
setting and reporting outcomes data 
Management of T1DM and T2DM shares many parallels including the central role of achieving good 
glycaemic control, but also some very important differences including the range of affected age 
groups, the potential of lifestyle interventions, and the choice and timing of pharmacotherapy. 
However, since T2DM accounts for 85-90 per cent of prevalent cases in Australia, diabetes 
management programmes for T2DM predominated in the current literature review. A limited 
number of programmes identified in this review targeted only T1DM, or both T1DM and T2DM, 
although people with T1DM made up less than 10 per cent of those enrolled in combined studies 
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(Reichert et al., 2014, Knight et al., 2012, Rasekaba et al., 2012b). In the following section, features of 
selected, secondary prevention programmes reporting clinical outcomes are summarised, but more 
detail about the individual programmes can be found in the Appendices. 
 
Type 1 Diabetes secondary prevention programmes 
According to Australian guidelines, most people with T1DM will receive care from an endocrinologist 
or diabetes specialist; however, they may also access GPs for routine monitoring of HbA1c and blood 
pressure, and other requirements such as vaccination against influenza (Australasian Paediatric 
Endocrine Group and the Australian Diabetes Society, 2011). Since 2005, GPs across Australia have 
been able to refer T1DM patients in need of help with self-managing their diabetes to the one-week 
long Dose Adjustment For Normal Eating (DAFNE) programme to learn how to estimate and balance 
diet and insulin injections, as well as how to better manage exercise, illness and alcohol consumption 
(McIntyre et al., 2010). An audit of patients at seven Australian diabetes centres after participation in 
DAFNE showed moderately improved glycaemic control, reduced weight and a reduced incidence of 
severe hypoglycaemia (McIntyre et al., 2010). An adolescent version of DAFNE has also been 
developed and this is promoted as TEAM T1. 
 
In rural and remote areas, access to specialist services may be limited and GPs are likely to be the 
main provider of primary care for T1DM. In this case, access to specialists and services within 
regional centres might be facilitated via telemedicine (Australasian Paediatric Endocrine Group and 
the Australian Diabetes Society, 2011). In response to the sometimes limited access to diabetes 
specialists for people with T1DM, a number of general practice-based programmes have been 
developed, and examples with reported outcome measures are briefly summarised here and 
described in more detail in the Appendices. 
 
The Rural Australian Diabetes – Inspiring Control Activity & Lifestyle (RADICAL) general practice-based 
T1DM programme was launched in 2007 (Goss et al., 2010). Based on a co-located core 
multidisciplinary team (GP, diabetes educator, mental health nurse/counsellor) and on-site HbA1c 
testing, the RADICAL programme provides proactive child and family emotional support and 
promotes insulin regimes that aim to match patient lifestyle, especially insulin pump therapy. This is 
consistent with most of the key programme features identified by Tricco et al. (2012) as discussed 
above: promotion of self-management, team changes, patient education and case management. 
Over a two-year period, implementation of the RADICAL model resulted in a significant increase in 
the annual number of contacts with credentialed diabetes educators, and reductions in HbA1c for 
children and adolescents, as well as improved patient satisfaction and quality of life. Notably, in the 
year before RADICAL was launched, approximately six per cent of 48 patients achieved an HbA1c 
≤7.5 per cent, and this increased to 36 per cent of 50 patients in 2009; and emergency department 
attendance and admissions to hospital for diabetes-related issues decreased from 23 per cent to 
eight per cent in 2008 (Goss et al., 2010). According to the study group, an important contributor to 
the success of RADICAL was the inclusion of a counsellor as part of the core team, as this was of 
benefit to the patient and their support network alike.  
 
A second example of GP-based diabetes management programmes in rural regions is the Diabetes 
Management Along the Mallee Track, which incorporated community risk assessment and point-of-
care testing (PoCT) to manage patients with diagnosed diabetes (T1DM and T2DM) in partnership 
with local GPs, allied health and community health nurses (Shephard et al., 2005). This service was 
offered irrespective of diabetes type and after 10 months the percentage of people achieving good 
glycaemic control (HbA1c<8%) increased from 59 per cent to 91 per cent. PoCT diabetes 
management programmes have been implemented in a number of rural and urban settings, 
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including Aboriginal communities, and an accreditation programme has been established for ongoing 
implementation (Shephard, 2006). Patient and GP satisfaction with PoCT programmes is high, and 
significant improvement in diabetes management is consistently observed. However, a systematic 
review found that a lack of good quality, long-term follow-up studies prevented overall conclusions 
being drawn on the effectiveness of PoCT in the general practice setting (Gialamas et al., 2010). 
Again, key features of this programme were team changes and case management, but further studies 
documenting outcomes and programme requirements are needed. 
 
Type 2 Diabetes secondary prevention programmes 
A number of secondary prevention programmes for T2DM were identified as being relevant to the 
Australian PHC setting; however, this review is limited to those with published outcomes data. In line 
with the different target populations, variability in the approach taken was evident, although most 
programmes focused on similar targets including HbA1c, blood pressure and lipid levels. Most 
programmes implemented changes through the use of multidisciplinary teams and upskilling of staff. 
Many of the other key criteria highlighted in Tricco et al.’s (2012) systematic review outlined above 
were also evident in programme design and these are briefly discussed in the following section. The 
individual programmes are presented in more detail in Appendices. 
 
Although clinical markers like HbA1c are only proxy/surrogate measure for diabetes management 
and risk for diabetes-related complications, HbA1c was the most common primary outcome to assess 
programme efficacy for diabetes management across the programmes reviewed. This is consistent 
with the evidence for a direct relationship between reductions in HbA1c and reduced rates of 
diabetes-related complications as demonstrated in the landmark UKPDS study (Stratton et al., 2000). 
Despite the availability of a large pool of different therapeutic options for diabetes, it is noteworthy 
that a large number of patients with diabetes fail to reach optimal glycaemic targets.  
 
While most programmes reported modest improvements in HbA1c of less than one per cent, many 
reported significant improvements in the proportion of people reaching glycaemic targets (Table 4). 
The rural Diabetes Management Along the Mallee Track programme reported a substantial 
improvement in those reaching target, increasing from 59 to 91 per cent, and, similarly, both the 
Australian Primary Care Collaboratives and Integrated primary-secondary care for complex diabetes 
programmes increased the proportion from approximately 20 to 40 per cent. Moderate 
improvement in mean HbA1c was reported in the Canadian St Joseph’s Primary Care Diabetes 
Support Programme, where intensive diabetes management with education for self-management 
provided by an expanded care team including a social worker, resulted in significant improvements in 
HbA1c by 1.1 per cent for T1DM and 0.87 per cent for T2DM over a period of six months. Longer 
term follow-up is needed to determine whether this level of control is maintained. The importance of 
mental/social health professionals in diabetes management was also noted in the RADICAL T1DM 
management programme outlined above. A similar level of HbA1c improvement was also observed in 
the Victorian Northern Alliance HARP diabetes programme, with mean improvements by 1.3 per cent 
after 12 months, based on multidisciplinary care and individualised education. Although in that 
programme specific mention of mental/social health workers was not made, the provision of 
individualised education may have provided people with additional support that resulted in 
improved self-management and coping. However, team changes and education per se are not 
sufficient to produce these improvements in HbA1c, with a number of programmes reporting more 
modest changes despite implementing similar but not identical programmes. Programme efficacy 
will also depend on the potential for improvement, people with good control are less likely to 
achieve major changes in HbA1c, and many studies reported better outcomes in those with poorest 
control. 
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Measurement of outcomes that can be modified is an important consideration. In addition to 
providing effective targets to reduce the risk for complications, modifiable risk factors like diet, 
physical activity, smoking, and alcohol consumption, could be utilised to understand why a 
programme is effective and which elements may be the biggest contributors. Further development of 
effective health behaviour education and/or self-management approaches requires evidence from 
existing programmes to show how much they contribute to observed changes.  
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Table 4 Summary of outcomes reported for secondary prevention programmes in diabetes 
NR= Not Reported; GP=General Pratitioner; T1DM=type 1 diabetes mellitus 
 
 
Programme Change in HbA1c at 12 months (%) Proportion with 
HbA1c≤7% 
Workforce 
RADICAL (Goss et al., 2010) -1.5% (over 3 years) 36% (versus 6% a 
baseline) 
GP, diabetes educator, mental health 
nurse/counsellor 
Diabetes Management Along the Mallee 
track (Shephard et al., 2005) 
-0.5% 63% (10 mo, versus 33% 
at baseline) 
GP, allied health and community health nurses 
Integrated primary-secondary care for 
complex diabetes (Askew et al., 2010, 
Jackson et al., 2010) 
 
-0.8% 
42% at 12 months versus 
21% at baseline  
GP Clinical Fellow, endocrinologist, diabetes 
educator, as needed dietician, psychologist, 
podiatrist  
Australian Primary Care Collaboratives 
(Australian Primary Care Collaborative, 
2014) 
NR 40% (versus 
approximately 25% at 
programme start) 
GP, Expert review panel 
Australian TLC Diabetes 
programme(Williams et al., 2012) 
-0.8% (versus -0.2% in control group) 20% (versus 15% in 
control group) 
Automated telephone response 
Northern Alliance HARP(Rasekaba et al., 
2012a, Rasekaba et al., 2012b) 
-1.3% NR Multidisciplinary team (endocrinologists, diabetes 
educators, dietitians) 
Logan Health Living(Eakin et al., 2013, Eakin 
et al., 2014) 
No change (but 1.4% weight loss) NR Nutritionist provides telephone based advice 
Diabetes, Your Life, Your Journey(Krebs et 
al., 2013) 
-0.4% at 6 mo, but no change at 9 mo NR Dietitian and practice nurse or diabetes nurse 
specialist 
Healthy Eating and Active Living in 
diabetes(Johnson et al., 2009) 
NR, but mean weight loss 1% NR Exercise specialist 
TeamCare model (Johnson et al., 2012a) -0.56% NR Nurse care manager and GP 
St. Joseph’s Primary Care diabetes support 
Programme (Reichert et al., 2014) 
-1.15% for T1DM (6 mo) 
-0.87% for T2DM (6 mo) 
NR Expanded care team including GPs, nurse 
practitioners, dietitians, social worker 
Intermediate Care Clinics for Diabetes 
(Halfyard et al., 2010, Sharp, 2010) 
-1.5% NR GP, specialists, community services including podiatry 
and dietetics 
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Team changes 
There is a large diversity in team arrangements across programmes. This is often dictated by the 
context and resources available. Several programmes identify the importance of upskilling; especially 
for nurses in the role of nurse practitioners or diabetes specialist nurse. Similarly, GPs specialising in 
diabetes management (GP with Special Interest) (Russell et al., 2013, Jackson et al., 2010) are central 
to many programmes identified in this review. In addition to these fundamental roles, allied health 
professionals and specialists play a vital role as part of the expanded care teams, most frequently 
including endocrinologists, podiatrists, psychologists (health and clinical), dietitians/nutritionists, 
optometrists/ophthalmologists and exercise specialists. The inclusion of specialists in the team 
allows for early identification of potential complications (e.g. eye and foot screening) and therefore 
early intervention to prevent further deterioration (Russell et al., 2013, Zhang et al., 2013). For 
populations that are not well connected to PHC providers, the addition of a social worker has also 
been identified as being beneficial (Reichert et al., 2014). 
 
Case management 
Programme fidelity is the extent to which delivery of an intervention adheres to the protocol or 
programme model originally developed (Kramer et al., 2009). Fidelity measurement has increasing 
significance for evaluation, treatment effectiveness research, and service administration in order to 
understand how transferable it is across a variety of settings and circumstances. With regard to 
context, the programmes described in this review suggest that population requirements influence 
the programme outcomes. For example, co-location strategies where team care is coordinated from 
one community-based location could be recommended for populations that are not strongly 
affiliated with a GP (TeamCare-PCN) (Johnson et al., 2012a). On the other hand, in urban settings, 
hub and spoke approaches can be considered (Wilson et al., 2014). Programmes that are more 
effective at improving clinical markers tend to have well-integrated primary/secondary models of 
care (Wilson et al., 2014, Russell et al., 2013). This type of horizontal integration requires 
relationships between organisations, professionals and patients. The Australian Primary Care 
Collaboratives programme is one of the few to address acceptability and capacity issues at the 
organisational level which may stall or enhance implementation (Knight et al., 2012).   
 
Promotion of self-management and patient education 
Programmes identified in this review provide limited detail on the patient education and self-
management aspects of the programmes. However, education for health professionals, (including 
upskilling), and referral to health professionals and organisation staff appears to be just as important 
as developing education for patients (Knight et al., 2012). Where education programmes have been 
developed, findings suggest they need to be personalised and well-integrated into community-based 
care (Wilson et al., 2014) and, importantly, they need to be culturally sensitive (Krebs et al., 2013). 
There is a strong role for allied health professionals (i.e. health psychologists, exercise physiologists, 
dietitians etc.) in secondary prevention programmes, including an increased focus on biopsychosocial 
assessment and behaviour change strategies.  
 
Education and self-management approaches are frequently undertaken in a group setting (Johnson 
et al., 2009, Krebs et al., 2013) and delivered in community settings. Often there is a dilution of effect 
over time and renewed awareness of the effective programme elements across a team of health 
professionals would be beneficial post-programme (Krebs et al., 2013). 
 
Cost considerations 
The NA-HARP hospital-based programme was the only approach that assessed the cost of providing 
the diabetes service (i.e. staffing costs). Cost data (staff annual salaries) or hourly rates (salary plus 
15% on-costs) for each staff member working in the diabetes service were obtained from 
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administrative data (Rasekaba et al., 2012b). Further cost modelling by the authors indicates that if 
diabetes management programmes are able to decrease admissions for vascular complications of 
diabetes, the potential for cost savings can be realised. The Brisbane Integrated secondary-primary 
care for complex diabetes management programme, which is based on upskilled GPs and 
multidisciplinary teams, reported an increase in the proportion of people achieving good glycaemic 
control (HbA1c<7%) from 21 to 42 per cent, but for just one-fifth the cost of usual care provided by a 
hospital outpatient clinic. 
 
Acceptance and implementation of programmes 
For policy and practice application of programmes like those identified in this review, scalability and 
cost need to be considered. However, very few programmes presented information on the cost of 
implementation. Programmes targeting diabetes management often measure efficacy, focusing on 
the internal validity of high-intensity health interventions in a controlled setting with a homogenous 
sample. It has been argued that this narrow focus does little to help understand what is effective in 
the real world (Wozniak et al., 2012) to assess health interventions. With this in mind, Canadian 
researchers have proposed and applied an expanded RE-AIM framework (Wozniak et al., 2012) to 
assess health interventions for diabetes and to identify facilitators, challenges, opportunities and 
lessons learned to be used in further programme development and implementation. The five 
dimensions are listed in Table 5.  
 
Table 5 RE-AIM framework 
Reach into the target population, this refers to the ability to identify and 
target populations at an organisational level including the absolute 
number, proportion and representativeness of individuals willing to 
participate in said intervention  
Effectiveness of the intervention  
Adoption by target settings, institutions and staff 
Implementation, including consistency and cost of delivery 
Maintenance of intervention effects over time. 
Adapted from Wozniak et al. (2012) 
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Summary and Discussion 
Primary prevention of T2DM and secondary prevention of diabetes-related complications in T1DM 
and T2DM are based on very different strategies, but both have been demonstrated to be feasible in 
clinical trials and to a varied extent in clinical practice.   
 
Primary prevention of T1DM is currently not possible and, although there is an intensive effort 
currently underway to identify interventions to delay pancreatic destruction and a number of genetic 
markers for T1DM have been identified, there is no recommendation for screening or intervention. In 
contrast, primary prevention of T2DM has been demonstrated in RCTs through the use of lifestyle 
interventions, and to a lesser extent pharmacotherapy, to target weight loss of five per cent or more 
of body weight together with improved diet and physical activity. However, translation of these 
findings in clinical practice has proven difficult because weight loss equivalent to that achieved in 
RCTs has only been demonstrated in less than 25 per cent of ‘real-world’ programme participants. 
Retention rates in clinical practice are also variable, although both the Life! and SDPP studies 
conducted in Australia reported good levels of retention compared to the UK Counterweight 
programme. Optimisation of current programmes to address reasons for this reduced efficacy and to 
further improve programme retention rates are now needed. However, longer-term follow-up of 
current programmes may reveal reductions in T2DM incidence in the future despite achieving only 
modest weight loss. The cost-effectiveness analyses based on modelling of ‘real-world’ scenarios, 
such as switching to pharmacotherapy when lifestyle programmes prove ineffective, are likely to 
provide a more realistic evaluation; but within programme/study economic analyses should also be 
encouraged to provide accurate costs and outcome data. Use of outcomes in cost-effectiveness 
analyses reported from RCTs, specifically from the DPP and DPS trials, are likely to overestimate the 
cost-effectiveness of programmes modelled in a clinical setting because of the lower weight loss 
achieved in the clinical setting. 
 
Secondary prevention in T1DM and T2DM refers to management strategies aimed at reducing the 
rate of diabetes progression and/or the development of diabetes-related complications. While 
HbA1c is by far the most common outcome used to measure improvement in diabetes management 
and risk for complications, and this reflects the level of evidence behind this relationship, increasingly 
it is being combined with other clinical markers including blood pressure, and cholesterol 
parameters, as a combined indicator. Outcomes that can be modified can be incorporated into an 
effective management programme. 
 
Team changes and self-management are commonly employed in the programmes reviewed here, 
and this is in line with findings of systematic reviews. Although a number of key programme 
elements have been identified, it should be noted that most programmes are specifically designed 
and refined to meet the needs of local populations and this may affect transferability. For example, 
co-location strategies where team care is coordinated from one community-based location could be 
recommended for populations that are not strongly affiliated with GP (TeamCare-PCN) (Johnson et 
al., 2012a). On the other hand, in urban settings, hub and spoke (Wilson et al., 2014) approaches can 
be considered. 
 
There is very little discussion in the literature about the acceptability of these programmes, not only 
for organisations and practices to undertake, but also for patients to participate. More effective 
programmes at improving clinical markers have well-integrated primary/secondary models of care 
(Wilson et al., 2014, Russell et al., 2013). This type of horizontal integration requires relationships 
between organisations, professionals and patients. The Australian Primary Care Collaboratives 
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programme is one of the few to address acceptability and capacity issues at the organisational level 
which may stall or enhance implementation (Knight et al., 2012). Programmes targeting diabetes 
management often measure efficacy, focusing on the internal validity and high-intensity health 
interventions in a controlled setting with a homogenous sample. It has been argued that this narrow 
focus does little to improve our understanding of what is effective in the real world. 
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Conclusions 
Primary prevention of T1DM is currently not possible, and hence despite the identification of a 
number of genetic markers screening is currently not recommended. Ongoing research is focused on 
preventing or delaying deterioration of the pancreas by targeting diet and environmental factors. 
 
Despite very strong evidence indicating that T2DM can be prevented, primary prevention 
programmes in the clinical setting and targeting those at high risk have not achieved equivalent or 
sustained weight loss in the majority of people enrolled. Further analyses of current programmes are 
required to identify facilitators and barriers to success, as well as the potential of more moderate 
weight loss to impact on future risk for diabetes. 
 
In line with the evidence, secondary prevention of incident complications and progression of 
established complications in T1DM and T2DM remains focused on improvement of glycaemic 
control. In a number of cases, PHC-based management programmes tailored to the individual and 
based on a multidisciplinary team approach have reported significant improvements. The success of 
programmes where teams include social or mental health professionals suggest that a holistic 
approach to care may be an important contributor to achieving care targets. Although numerous 
programmes were identified, for most it was not possible to identify data on outcomes. In view of 
the resource and cost consequences of primary and secondary prevention programmes for diabetes, 
generating appropriate data on which to evaluate programmes is essential and should be a future 
priority. 
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Appendices 
 
Definition of quality improvement strategies targeting 
health systems 
The following definitions are as applied in Tricco et al.’s (2012) the meta-analysis and more detail is 
available from the publication. 
 
Case management 
Any system for coordinating diagnosis, treatment, or routine management of patients (e.g. 
arrangement for referrals, follow-up of test results) by a person or multidisciplinary team in 
collaboration with, or supplementary to, the primary-care clinician. For a RCT to qualify, the case 
management had to happen more than once.  
 
Team changes 
Changes to the structure or organisation of the PHC team were defined as present if they met certain 
criteria: 
• Adding a team member or shared care—e.g. routine visits with people other than the primary 
physician (including physician or nurse specialists in diabetic care, pharmacists, nutritionists, 
podiatrists). 
• Use of multidisciplinary teams—i.e. active participation of professionals from more than one 
discipline (e.g. medicine, nursing, pharmacy, nutrition) in the primary, routine management of 
patients. 
• Expansion or revision of professional roles (e.g. nurse or pharmacist has a more active role in 
monitoring of the patient or adjusting drug regimens). 
 
Electronic patient registry 
General electronic medical record system or electronic tracking system for patients with diabetes. 
 
Facilitated relay of information to clinicians 
Clinical information collected from patients and transmitted to clinicians by means other than the 
existing medical record, including, passports, referral systems, and dietary information (vs purely 
clinical information). In general, the patient should be facilitating the relay. To be included, the 
information must get to someone with prescribing or ordering authrority.  
 
Continuous Quality Improvement 
Interventions explicitly identified as involving the techniques of continuous quality improvement 
(CQI), total quality management, or plan-do-study-act, or any iterative process for assessing quality 
problems, developing solutions to those problems, testing their effects and then reassessing the 
need for further action. 
 
Audit and feedback 
Summary of clinical performance of health care delivered by an individual clinician or clinic over a 
specified period, which was then transmitted back to the clinician (e.g. the percentage of a clinician’s 
patients who achieved a target HbA1c concentration or who underwent dilated-eye examinations 
with a specified frequency). 
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Clinician education 
Interventions designed to promote increased understanding of principles guiding clinical care or 
awareness of specific recommendations for a target disorder or population of patients. 
Subcategories of clinician education included conferences or workshops, distribution of educational 
materials (written, video, or other), and educational outreach visits (i.e. academic detailing).  
 
Clinician reminders 
Paper-based or electronic systems intended to prompt a health professional to recall patient-specific 
information (e.g. most recent HbA1c value) or to do a specific task (e.g. foot examination). 
 
Financial incentives 
Interventions with positive or negative financial incentives directed at providers (e.g. linked to 
adherence to some process of care or achievement of some target outcome).  
 
QI strategies targeting patients 
Education of patients 
Interventions designed to promote greater understanding of a target disorder or to teach specific 
prevention or treatment strategies, or specific in-person education (e.g. individual or group sessions 
with diabetes nurse educator; distribution of printed or electronic educational materials). 
Interventions with education of patients were included only if they also included at least one other 
strategy related to clinician or organisational change.  
 
Promotion of self-management 
Provision of equipment (e.g. home glucose meters) or access to resources (e.g. system for 
electronically transmitting home glucose measurements and receiving insulin dose changes based on 
those data) to promote self-management. Interventions promoting self-management were included 
only if they also included at least one other strategy related to clinician or organisational change. 
 
Reminder systems 
Any effort (e.g. postcards or telephone calls) to remind patients about upcoming appointments or 
important aspects of self-care. Interventions with reminders were included only if they also included 
at least one other strategy related to clinician or organisational change.  
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Primary prevention programmes 
Life!Taking action in diabetes 
Life!Taking action in diabetes (Life!) is the systematic, full-scale T2DM prevention programme 
launched across the state of Victoria in 2007 with funding from the Victorian government (Dunbar et 
al., 2014). The Life! programme structure is based on the Finnish DPS, the greater green Triangle 
(GGT) diabetes prevention programme, and the good Ageing in Lahti region (GOAL) Implementation 
trial. A Life! pilot study known as the Melbourne Diabetes Prevention Study (MDPS) was reported in 
2012, and a larger, randomised MDPS sub-study aimed at evaluating the effectiveness and cost-
effectiveness of the Life! programme delivered as an individual session plus five group sessions is 
ongoing (Davis-Lameloise et al., 2013, Janus et al., 2012). The widely implemented Life! programme 
is composed of six pre-defined group intervention sessions (8-15 people) provided over an eight-
month period, with programme quality control measures and participant tracking of personal 
progress (Dunbar et al., 2014). Patient referral is via one of four pathways: 1) referrals generated 
through Life! providers or facilitators; 2) family physician/health professional; 3) social marketing via 
telephone/web support systems; and 4) workplace-generated recruitment. Of these, pathways one 
to three contributed 36.2, 30.2, and 28.2 per cent respectively of programme participants by June 
2011, and 14,819 referrals had been received with 57 per cent commencing the first session and 37 
per cent completing the programme (Dunbar et al., 2014). General practices are encouraged to refer 
eligible patients into the Life! programme via the General Practice Case-Finding Funding Initiative 
(http://www.lifeprogram.org.au/for-health-professionals), receiving: $20 for each eligible patient 
referred; and$30 when the patient completes the introductory session. 
 
Life! service providers then deliver the Life! intervention programme. Life! service providers are paid 
$400 per participant to cover programme and participant-related resources (as two instalments after 
sessions one and five), and therefore this acts is an incentive to actively promote uptake and 
retention (Dunbar et al., 2014). 
 
Life! programme goals are based on the DPS: 
1. No more than 30 per cent of energy consumed from fat 
2. No more than 10 per cent of energy from saturated fat 
3. At least 15g fiber/1,000 kcal 
4. At least 30min/day of moderate-intensity physical exercise 
5. At least 5 per cent weight reduction. 
 
Risk assessment  
The Australian diabetes risk tool AUSDRISK is used to assess individual risk for developing T2DM. 
Programme entry is currently dependent on the AUSDRISK score and personal history satisfying one 
or more of the following (Dunbar et al., 2012): 
 aged 50 years and over, AUSDRISK score of 12 or more (revised down from a score of 15 in 
the original programme) 
 aged 18 years or older, indigenous Australians of Aboriginal and Torres Strait Islander 
descent who are at very high risk, AUSDRISK score of 12 or more 
 aged 18 years or older, Aboriginal and Torres Strait Islander descent or previously diagnosed 
with high-risk conditions such as GDM or atherosclerosis-related CVD. (reflects revisions to 
programme eligibility criteria in 2010) 
 aged 18-39, AUSDRISK score of 12 or more, and having received an occupational health 
assessment. 
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Outcomes 
Based on 6,632 participants, the following significant (p<0.001) changes were noted between 
sessions one and five (in brackets corresponding outcomes are provided for those completing 
sessions one to six): 
 approximately 7.9 (25.3) per cent of the cohort recorded weight loss greater than five per 
cent  
 compared to a baseline level of 28.8 (31.0) per cent, 59.5 (65.1) per cent reached dietary 
goals (intake of fat <30% of energy; intake of saturated fats <10% of energy; increase of 
dietary fibre to equal or greater than 15g/1,000 kcal) 
 compared to a baseline level of 10.3 (11.3) per cent, 15.8 (17.6) per cent achieved an 
increase of physical activity to at least 4h/week. 
 
Risk reduction 
The primary endpoint of diagnosed diabetes has not been reported to date. However, based on 
linear interpolation from the DPS, reported 58 per cent reduction in diabetes risk over four years for 
an average weight loss of approximately five per cent of body weight, the average weight loss 
reported for those completing six sessions (i.e. 2.3kg or 2.8% of body weight in Life!) equates to a 32 
per cent reduction in diabetes risk over four years.  
 
Role of technology 
Social marketing and use of website promotion and a 24-h telephone help line (13 RISK) facilitated 
recruitment of high risk individuals. Participants were provided with a manual to record lipid, blood 
pressure and blood glucose levels plus their individualised goals and outcomes; but there was no 
indication that this was an electronic device or based on entry of information via computer based 
technology. As a condition for payment, Life! facilitators (persons employed by non-profit, public 
sector, or private agencies and having completed a Life! training course) are required to enter data 
for performance measurement, continuous quality improvement, and evaluation. 
 
Aboriginal Life! Taking action on diabetes 
The Aboriginal Life! programme launched in 2009 is an extension of the Life! Taking action on 
diabetes programme. The core model is based on the ‘Road to good health’ course developed and 
piloted by Goulburn Valley Division of General Practice together with Rumbalara health workers and 
services (HealthInfoNet, 2014). As with the Life! project outlined above, Aboriginal Life! comprises six 
interactive group sessions tailored to each group’s needs. Adaptation of the model to meet 
Indigenous needs included (Alexander, 2013): 
 Providing information and education that relates to ‘real life’. Being aware of current 
behaviour among Aboriginal peoples helps understand their information needs, so pragmatic 
strategies can be provided which can be put into action immediately and implemented 
locally.  
 The use of clear and simple language and incorporation of visual resources.  
 Encouraging a conversational approach, rather than an emphasis on a ‘reading and listening’ 
approach and dependence on written material.  
 The social context was taken into account, fostering group support by encouraging family 
and community members to take part in the programme. Messages emphasised maintaining 
good health for one’s family or community, rather than focus on an individual.  
 It was recommended not to call it a diabetes prevention programme. The community 
accepted the name Road to Good Health and helped design a logo.  
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Sydney Diabetes Prevention Programme (SDPP) 
The SDPP (also known as Prevent Diabetes Live Life Well) is a diabetes prevention programme 
initiated in three Divisions of General Practice in NSW, Australia, and delivered in a community 
setting. SDPP was delivered to 1,550 participants, including 100 Indigenous, 100 Arabic speaking, and 
100 Chinese speaking people, between 2008 and 2011.(Colagiuri et al., 2010) The five aims of the 
SDPP were based on the DPS: at least 30min/day of moderate to vigorous intensity physical activity, 
reduction in the intake of energy from total fat to less than 30 per cent, fibre intake of at least 
15g/1,000 kcal, a weight reduction of five or more per cent at 12 months. The SDPP placed particular 
emphasis on specifying use of resistance training. Following an individual session, participants attend 
three two-hour group sessions held over a six to eight week period. Material for Indigenous 
participants was modified to take account of cultural issues.  
 
An adaptation of the SDPP was developed for the Prevent diabetes live life well programme managed 
by the Tharawal Aboriginal Medical service in NSW. 
 
Risk assessment  
Risk was assessed using the AUSDRISK tool. Individuals with an AUSDRISK score of 15 or more were 
invited to participate. 
 
Risk reduction 
After completion of the 12-month lifestyle modification programme of the SDPP, the mean weight 
loss at one-year follow-up was approximately 2kg or two per cent of body weight based on a 
preliminary study evaluation (Cardona-Morrell, 2011). However in a three-year follow-up, weight 
losses of 3.8kg, and 1.8kg at two years, and 2kg at three years were reported (Vita and Colagiuri, 
2013). Participants reported eating less fat and more fibre, but physical activity did not change. 
Predictors of five per cent weight loss were lower saturated fat intake at baseline, high education 
and higher number of contacts with the lifestyle officer (Cardona-Morrell, 2011). A post-study 
analysis of the SDPP cohort found significant predictors of enrolment into the lifestyle programme to 
be physical inactivity, family history of diabetes, and history of high blood glucose levels (Laws et al., 
2012). Individuals who smoked, were born in a country with high diabetes risk, were taking blood 
pressure-lowering medications, or consumed little fruit and vegetables were significantly less likely 
to enrol (Laws et al., 2012). 
 
Role of technology 
For those not able to attend, the same material was presented via telephone. At three, six, and nine 
months, participants were telephoned to enquire about progress and provide assistance with 
behaviour change as required. Individual assessments were conducted at 12 months. 
 
 
Healthy Eating Activity and Lifestyle (HEAL™) 
The HEAL™ programme is a group-based, 8-week, education and lifestyle modification programme 
designed to support people at risk for obesity-related conditions of cardiovascular disease and T2DM, 
but also for those requiring help to manage their weight, established T2DM, heart disease or 
metabolic condition (Hetherington and Borodzicz, 2013). GPs are encouraged to monitor participant 
progress at six and nine months after starting the programme, and to be eligible, patients must be 
referred from their GP and either have T2DM and a GP management plan, be at high risk of 
developing T2DM, have two or more CVD risk factors, or a BMI greater than 30. 
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Risk assessment  
GP referral. 
 
Risk reduction 
Over a three-year period 1,737 people completed the HEAL™ programme, with a retention rate of 61 
per cent. Outcomes for 1,500 people were available for evaluation and demonstrated the following 
changes at 8 weeks: weight reduction by one kilogram (1% change), waist circumference reduction 
by 2.4cm, physical activity increased by 36.8 minutes per week, average daily sitting reduced by one 
hour (17% reduction), SBP reduced by 3.1 mmHg, DBP reduced by 2.4 mmHg, improved dietary 
intake, 6-minute walk (11%), and 30-second chair rise (18%). A five-month post-programme follow-
up demonstrated maintenance of all improvements and continued improvement in physical activity 
and weight loss. 
 
Role of technology 
The role of technology is unknown. 
 
UK Counterweight Programme 
The Counterweight programme is an evidence- and theory-based intervention for weight 
management delivered through general practice and shown using the NICE obesity health economic 
model in the UK setting to be highly cost-effective (and cost saving in most scenarios modelled) 
(Laws, 2004, McQuigg et al., 2008, Trueman et al., 2010). First launched in the UK in 2000, the core 
model is based on four phases: 1) practice audit and needs assessment; 2) practice support and 
training; 3) practice nurse-led patient intervention; and 4) evaluation. Programme refinement is an 
ongoing process; however, the core model involves patient attendance at six individual or group 
sessions over a 3-month period with follow-up at three quarterly support visits (Ross and 
Counterweight project team, 2012, Laws, 2004). In phase one, structured interviews with GPs and 
practice nurses (PNs) are used to determine approaches used to manage obese patients and the 
equipment available for this. Then in phase two, a one-hour workshop provides feedback on the 
audit results and training for GPs and PNs. The GP’s role is to raise the issue of weight, the benefits of 
weight loss and to screen for programme suitability using a flip-chart based set of tools. PNs 
undertake a 6-8 hour training programme on delivery of the lifestyle intervention; the course is 
delivered by weight management advisers who continue to mentor PNs for approximately six months 
or until competency reached. Average total general practice time to deliver the programme was 130 
minutes per patient (Haslam, 2010). Based on an evaluation between 2000 and 2005, mean weight 
loss at 12 months was -2.96 kg among attenders, with 45 per cent of participants completing 12 
months and 31 per cent meeting the target of greater than five per cent weight loss (2008). A 
subsequent evaluation of the programme implemented across 13 Health boards in Scotland between 
2006 and 2010 demonstrated similar weight loss and retention rates in 6,715 attenders, except for 
the 12-month retention rate which was lower at 28 per cent (Ross and Counterweight project team, 
2012). The programme now offers two additional models: Counterweight plus, a year-long 
programme with or without pharmacotherapy for severe and complicated obesity; and 
Counterweight families, recognising the importance of influence from within a family unit on 
behaviour change. A feasibility study of the Counterweight plus programme demonstrated an 
average weight loss of 12.4 kg (-9.1%) based on all participants, and a retention rate of 64 per cent 
(Lean et al., 2013). Counterweight is currently being trialled in studies based on Sydney and Adelaide. 
(http://compare-phc.unsw.edu.au/content/counterweight-trial-sydney)  
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Risk assessment  
Patients are initially identified by the GP, and then screened by PNs based on calculation of BMI and 
administering a ‘Dieting Readiness’ test to assess a patient’s suitability for the Counterweight 
programme. Patients are prioritised for Counterweight if they have BMI≥30 kg/m2 or BMI≥28 
kg/m2 with co-morbidities; others at lower risk are encouraged to use self-help and commercial 
programmes. 
 
Risk reduction 
Assessment of obesity-related disease markers or risk factors has been difficult because the 
programme has insufficient funds and there is no control group for comparison.  
 
Role of technology 
There was no mention about the role of technology, with the programme focusing more on changes 
to staff roles after attending workshops to upskill GPs and PNs. 
 
Support Health Information, Nutrition and Exercise (SHINE) study 
The aim of the randomised US-based SHINE study was to compare delivery of the Diabetes 
Prevention Programme (DPP) using individual telephone sessions (IC) versus group telephone 
sessions (CC) (Weinstock et al., 2013).   
 
Although outcomes from a three-year long follow-up of SHINE have been very recently published we 
were unable to identify any non-trial accounts for implementation of this programme in PHC. 
However, the SHINE programme is specifically designed to be delivered within the PHC setting by 
diabetes educators (in the trial this included registered nurses, family practice nurses, licensed 
practice nurses and a medical office assistant) and coaches (dietitians). The programme is based on a 
16-session core curriculum covering goal-setting, self-monitoring, diet/activity modification and 
problem-solving; and this is further enriched with group diet and fitness classes. Participants are 
asked to keep a log to quantify diet and activity behaviours which they send to their educator and 
coach every month and give to the relevant primary care providers. Reported outcomes from the 
trial were collected at six, 12, and 24 months, and recently a 36-month follow-up was reported to 
assess outcomes one year after the programme had finished (Trief et al., 2014). At the three-year 
follow-up, mean weight loss was similar to outcomes at year two and significant at -6.4kg for CC 
versus -2.35kg for IC. In terms of the pre-defined endpoint, approximately 51 per cent of CC 
participants and 29 per cent of IC achieved weight loss of at least five per cent over the three year 
period. Interestingly, with respect to the proportion of participants achieving at least five per cent 
weight reduction, there was no difference between study completers and non-completers at three 
years for the CC group (51% vs 50%, respectively) but a significant difference for the IC group (37.8% 
vs 5.6%, respectively). Although both groups also recorded improvement in HDL cholesterol, there 
was no mention of any impact on physical activity or diet for either group. It was also notable that 
the IC group, but not the CC group, reported an increase in blood pressure over this time period. 
 
Risk assessment  
Participants for the SHINE trial were selected based on being aged 18 years or older, having a BMI of 
≥ 30kg/m2, and presence of metabolic syndrome according to the International Diabetes Federation 
criteria of: triglyceride level ≥150 mg/dl or triglyceride treatment, HDL-cholesterol <40 mg/dl (males) 
and <50 mg/dl (females) or HDL treatment, elevated blood pressure (systolic ≥130 or diastolic ≥85 
mmHg) or treatment of diagnosed hypertension, and high fasting plasma glucose (≥100 mg/dl). 
Diagnosed diabetes or presence of severe medical problems that might interfere with participation 
were grounds for exclusion.  
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Risk reduction 
The study was not designed to assess the hard endpoint of diabetes prevention but relied on 
achieving weight loss ≥5 per cent of initial body weight. This is similar to the DPP target of seven per 
cent or greater weight loss which was associated with reduced risk for T2DM. 
 
Role of technology 
Apart from use of telephone conference call for the group sessions, no other mention of technology 
was noted in the published accounts. However, it would of interest to know how log book entries 
were made and whether this was, or could be, implemented through use of electronic technology. 
 
Building on Existing tools to Improve chronic Disease Prevention and Screening in Family 
Practice (BETTER) 
The aim of the Canadian BETTER randomised trial was to improve uptake of clinically effective 
chronic disease prevention and screening (CDPS) actions for primary prevention of heart disease and 
diabetes, screening for colorectal, breast and cervical cancers, and relevant lifestyle factors through a 
multifaceted intervention in primary care (Campbell-Scherer et al., 2014, Grunfeld et al., 2013, 
Manca et al., 2014). Although not designed specifically to prevent diabetes, the list of CDPS actions 
included increased physical activity, weight control referral, and blood sugar screening.  
 
The BETTER RCT (n=789) compared use of usual care versus practice-level intervention with a 
practice facilitator who supported GPs with respect to using the electronic medical record (EMR) 
based algorithm to guide care and monitor actions, and/or a patient-level intervention with a 
practitioner (upskilled nurse practitioner, nurse or dietitian) from within the practice who spent one 
hour with intervention patients to develop personalised ‘prevention prescription’ and direct them to 
relevant practice or community resources. After 12 months, the effect on CDPS actions of the 
prevention practitioner intervention was significant (improved by 32.5% vs control) but the 
prevention facilitator was not. In addition, there was an indication that physical activity improved by 
12.6 per cent and healthy diet by 7.2 per cent, with no impact on weight control or smoking 
cessation (Grunfeld et al., 2013). However, it should be noted that the study was not designed or 
powered to test the effect of the intervention on each action separately and this requires 
verification. The BETTER study was based in urban settings, and a second study, BETTER2, is assessing 
outcomes in rural settings and further refining the BETTER pathways. 
 
Risk assessment  
With respect to the diabetes-specific pathways included in BETTER, no specific risk calculator is 
indicated. However, screening includes blood pressure, lipid levels, waist circumference, and BMI 
assessment. 
 
Risk reduction 
The impact of BETTER on diabetes incidence has not been reported to date. However, as noted 
above, improvements in activity and diet were observed after 12 months. 
 
Role of technology 
Optimal use of EMR with integrated algorithms for care is the core technology of the BETTER 
programme. Based on a comprehensive search of existing tools and guidelines (including 
international sources), evidence based algorithms were developed for primary prevention of 
diabetes and coronary artery disease (Campbell-Scherer et al., 2014). Recommendations for patients 
aged 40-65 were reformatted into algorithms to facilitate clinical decision-making and encourage 
implementation. 
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Ongoing primary prevention programme trials without outcomes data 
 
MAGDA 
The Mothers After Gestational Diabetes in Australia diabetes Prevention Programme (MAGDA-DPP) is 
a randomised, postnatal prevention study aimed at assessing the effectiveness of an adaptation of 
the Life! programme in women with a diagnosis of GDM in their most recent pregnancy (Shih et al., 
2013, Shih et al., 2014). Intervention goals are as described for Life!, and programme delivery is 
achieved via a one-to-one first session followed by five group sessions with an emphasis being placed 
on content tailored to the participants (e.g. postnatal depression, sleep deprivation). A minimum 
number of 430 participants are required, and recruitment commenced in Melbourne in 2011 and 
Adelaide in 2012. To date, a total of 340 women have given consent and 134 have been randomised 
to either the intervention or the control group (Shih et al., 2013). Primary endpoints for MAGDA are 
as follows: 12-month change in diabetes risk as determined by changes in fasting plasma glucose 
level, weight, or waist circumference. Secondary endpoint changes in 2-hour OGTT, lipids, blood 
pressure, depression, quality of life, physical activity and diet. 
 
PREVIEW 
PREVention of diabetes through lifestyle intervention, PREVIEW, is an international five-year study to 
determine the best lifestyle strategies for weight loss and prevention of T2DM. 
(http://preview.ning.com/) A total of 15 partner organisations (mostly European) are taking part in 
the trial including Sydney University and the University of Auckland. The dietary regimen is based on 
previous research demonstrating that low glycaemic index foods and moderately high protein diets 
are associated with sustained weight loss (Larsen et al., 2010). “As of the end of March 2014, a total 
of 7,400 subjects have been pre-screened, 2,450 have been screened, and 1,050 subjects found 
eligible for the clinical trial. The average age of the eligible subjects so far is 52 y, divided into 735 
females and 315 males. During the initial LCDiv phase (using Cambridge Weight Plan LCD products), a 
total of 80 per cent of the subjects have achieved the target weight loss as hypothesized in the 
PREVIEW concept” (http://preview.ning.com/profiles/blogs/some-good-news-recruitment-in-
the-preview-intervention-study-is)  
 
                                                          
iv LCD = low calorie diet. 
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Australian secondary prevention programs 
 
Integrated primary-secondary care for complex diabetes in the community 
This programme is a community-based model of care led by a general practitioner with advanced 
skills and an endocrinologist partnership. The programme is based on the Brisbane South Complex 
Diabetes Service (BSDS) Programme (Jackson et al., 2010) and the Inala Chronic Disease management 
Service (ICDMS) (Askew et al., 2010). 
 
A prospective open controlled trial was undertaken comparing the programme delivered by GPs with 
advanced skills to usual care delivered via the hospital diabetes outpatient department. Outcomes 
included primarily HbA1c concentration at 12 months, but also serum lipids and blood pressure. The 
mean change in HbA1c concentration in the intervention group was -9mmol/mol (-0.8%) at 12 
months and in the usual care group it was -2mmol/mol (-0.2%) (95% CI -5.1). The percentage of 
patients in the intervention group achieving the HbA1c target of ≤53 mmol/mol (7%) increased from 
21 to 42 per cent (P<0.001); for the usual care group, there was a one per cent increase to 39 per 
cent of patients attaining this target (P=0.99). There were some differences across the intervention 
group that may have influenced results, including age, gender, country of birth and education level. 
Clinically, the intervention group had higher baseline HbA1c concentration and lower blood pressure, 
neuropathy rates, amputation rates and serum creatinine concentration, which may have influenced 
the results.  
 
Cost per visit calculation based on Medicare and state health costing (excluding pathology), has 
shown that the intervention model is delivered at approximately one-fifth of the cost per visit 
compared with that of the usual care group, allowing a greater number of patient follow-up visits 
whilst still delivering clinic activity at a lower cost than usual outpatient department care (Russell et 
al., 2013). 
 
A RCT, which builds on the promising results described above but in a larger, more robust research 
design and addressing key methodological issues identified in their study, is currently underway 
(Zhang et al., 2013). 
 
Self-management 
All patients were offered a self-management course, usually around weight loss, conducted by the 
allied health team, although attendance was poor at six weeks and three months (Zhang et al., 2013, 
Russell et al., 2013).  
 
Team changes 
Initial assessment was undertaken by a credentialed diabetes educator care coordinator. Attending 
the clinic are two GPs with special interests known as ‘GP Clinical Fellows’, a GP training registrar, an 
endocrinologist, a diabetes educator and, as needed, a dietitian, psychologist and podiatrist. Medical 
care is led by a GP Clinical Fellow in partnership with an endocrinologist. During the ‘Diabetes Clinic’, 
the plan is discussed with the attending endocrinologist, who then briefly co-consults with the 
patient and Clinical Fellow together to finalise the approach. This co-management model allows the 
endocrinologist to attend 2–3 times the number of patients per clinic than is possible via the 
traditional specialist outpatient department model. 
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Patient education 
‘Diabetes clinic’ consists of a single four-hour session involving 2-3 GPs with Special Interest in 
diabetes management, the diabetes educator and podiatrist. Additional time with the diabetes 
educator is usually organised during the same clinic. The education programme adopted National 
and International guidelines, including the clinical targets relevant at that time. Case-based 
education sessions were also offered to referring GPs and practice nurses. 
 
Case management 
Comprehensive screening assessment is undertaken by a credentialed diabetes educator care 
coordinator including medication, diabetic history, retinal photographs, foot assessment, depression 
screen, and appropriate blood and urine testing. At the ICDMS diabetes clinic, the patients would see 
the GP Clinical Fellow, who reviewed and extended the diabetes nurse educator screening 
assessment and developed a patient-specific management plan. The GP Clinical Fellow would briefly 
consult the endocrinologist to review the management plan and then both would co-consult with the 
patient to finalise the management approach. 
 
This screening assessment is prior to attending a ‘Diabetes clinic’. All patients at clinic are first 
assessed by one of the Clinical Fellows, who clarify the history and medications, examines the 
patient, interprets the retinal photographs and pathology results, and drafts a management plan 
addressing glycaemic control, blood pressure, lipids, lifestyle, diabetes complication management 
and patient priorities. Additional time with the diabetes educator is usually arranged for the same 
clinic, and other allied health appointments at a time convenient for the patient. Patients initiating or 
altering insulin were enrolled in the Insulin Stabilisation Service, where patients are contacted by 
telephone twice weekly by the diabetes educator regarding insulin adjustment, according to defined 
protocols. The diabetes educator contacts all patients by telephone or, if attending the clinic in 
person, at six weeks and three months to assess progress, motivate and problem-solve any barriers 
to diabetes management.  
 
Facilitated relay of information to primary clinician 
Evidence based guidelines inform all management planning. The patient’s GP is kept closely informed 
of care management (currently by letter but this is expected to change to a shared web-based 
record). The patient’s latest GP Management Plan or Team Care Arrangement is included with the 
booking visit, and to ensure patients have been appropriately assessed and supported by diabetes 
education and dietary and lifestyle advice before referral. The management plan is sent to the 
patient’s usual GP within one week, with expectations of the service, patient and GP clearly outlined. 
GPs are provided with a direct contact number at the service for queries, concerns and rapid 
reassessment of patients if required. Patients were discharged back to their referring GP once 
glycaemic, lipid and blood pressure targets were achieved, or after 12 months if it was felt no further 
improvement could be achieved. The GP is advised to continue the usual cycle of care and is given 
some parameters for future re-referral of that individual patient. 
 
Australian Primary Care Collaboratives Programme 
Quality improvement collaboratives (QIC) are multifaceted interventions that bring together a range 
of strategies including case management, team changes, patient education, care algorithms and 
information technology changes. The Australian Primary Care Collaboratives (APCC) is a model for 
improvement based on implementing change in small manageable cycles and identifying where a 
change actually leads to an improvement (Australian Primary Care Collaborative, 2014). A panel of 
experts is tasked with identifying evidence on a topic including measures and change principles, and 
developing strategies and ideas for implementing change. 
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Divisions of General Practice were invited to recruit a number of health services to the programme. 
Eight hundred and eleven small teams from health services, usually comprising a GP and one other, 
attended a series of workshops, including orientation describing the programme. Health services that 
went on to commit to the collaborative programme (n = 743) received additional support to collect 
baseline data across several waves including diabetes, coronary heart disease and access. Teams 
attended three learning workshops separated by activity periods of three months. The two-day 
interactive workshops addressed change principles, the evidence behind them and quality 
improvement. Health services that produced good results were used in subsequent workshops as 
exemplars. Ideas, successes and failures were shared between health services. Plan-do-study-act 
(PDSA) cycles were taught. During activity periods, teams used this approach to implement change 
principles, submit outcome measures and monthly PDSA cycle reports. Support was provided to 
reinforce the messages of the workshop and advise teams on how to meet challenges as well as help 
with software installation. Health services received monthly feedback on their progress compared 
with their wave and assistance was provided to reflect on the wave. Currently, there are more than 
1,500 Australian general practices in the APCC programme (Australian Primary Care Collaborative, 
2014). 
 
Outcomes 
Based on data for 1,850 patients in the year between May 2013 and February 2014, recording of 
HbA1c has improved and the proportion with HbA1c≤7 per cent has increased from 30 per cent to 
40 per cent over that time. However, the proportion with HbA1c>10 per cent has remained relatively 
unchanged over that same period at approximately three per cent. It should be noted that the 
evidence goal for the QIC method is not to determine whether the method is universally ‘effective’ or 
‘ineffective’ across diverse setting and quality problems. 
 
The QIC programme measures for improvement identify indicators at the organisational level and 
specify the number of patients on the register; and also context-specific clinical outcomes; for 
example, the percentage of patients with diabetes with a last recorded HbA1c ≥7 within the last 12 
months, percentage of patients with diabetes with a last measured low-density lipoprotein 
cholesterol (LDL-C) <2 mmol/litre, percentage of patient with diabetes with a last recorded BP 
reading of ≤130/80 within the last 12 months. Consideration is given at the outset about the 
measures chosen to reflect best evidence. Capacity gaps are also identified as concepts: for example, 
disease registers, disease coding, team care and population management were unfamiliar to many 
practices in this study.  
 
Self-management 
No detail available. 
 
Team Changes 
For the health professionals working in these practices, existing expertise was commissioned to 
create software that could search clinical record systems to collect outcome measures electronically. 
Educational experts were involved to design interventions to teach quality improvement. 
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Patient Education 
No detail available.  
 
Case management 
No detail available. 
 
Facilitated Relay of Information to primary physician (information technology) 
The APCC programme uses the Pen Clinical Systems Clinical Audit Tool (PCS CAT) system to collect 
the measures from practices’ clinical software, and this can also be used to provide feedback and 
alerts for patient management within the practice. In addition, the APCC programme has a web 
portal known as qiConnect where participating practices lodge their monthly data electronically and 
can review their progress over time. This is a secure network with a unique log-in. The PCS CAT 
system is compatible with the following clinical software: 
 Medical Director 2 
 Medical Director 3 
 Best Practice 
 Genie 
 Zedmed 
 practiX 
 Communicare 
 Medinet 
 MedTech32. 
 
Australian TLC Diabetes programme 
Telephone-Linked Care (TLC) Diabetes system (Williams et al., 2012) is an automated interactive 
telephone system, developed collaboratively by the Australian research team and researchers at the 
Medical Information Systems Unit, Boston University, USA. 
 
A RCT of patients with poorly controlled diabetes has been undertaken to assess the efficacy of the 
TLC telephone coaching programme (Varney, 2013). Williams et al. (2013) reported a statistically 
significant difference in HbA1c at six months between the usual care and TLC Diabetes arms. HbA1c 
significantly decreased from 8.7 per cent (8.8%) to7.9 per cent (8.0%) in the TLC Diabetes arm, 
compared with 8.9 per cent (9.0%) to 8.7 per cent (8.9%) in the usual care arm. There was some 
evidence that the difference in HbA1c at six months between study arms increased with baseline 
HbA1c (p=0.09) for the interaction term in regression model. This suggested that the difference in 
six-month HbA1c between TLC and usual care patients was greater in patients with high baseline 
HbA1c values (i.e. those with poorer control) than in patients with low values. Of participants in the 
intervention arm, 20 per cent achieved HbA1c levels of 7.0 per cent or lower (95% CI 9.6-29.7), 
compared with 15 per cent (95% CI 4.4-24.7) in the usual care arm (p=0.32).  
 
Psychological wellbeing as measured by mental health-related quality of life (mental HRQL) improved 
in the TLC Diabetes group, compared with those in the usual care group where mental HRQL 
decreased marginally. No differences were observed in physical HRQL between the usual care and 
intervention arms (p=0.7).  
 
The mean number of completed calls for the Australian TLC Diabetes participants during the six-
month intervention was 18 (±6), ranging between two and 27 calls, with a mean call duration of 11 
minutes (±1). The mean percentage of completed calls out of the expected weekly calls for all 
individuals in the intervention condition was 76 per cent (±22). 
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Self-management 
The Australian TLC Diabetes system has been designed to improve diabetes management by 
targeting the following key self-management behaviours: blood glucose testing, nutrition, physical 
activity and medication-taking. Participants were requested to make weekly calls to the system over 
six months, with calls lasting five to 20 minutes, depending upon the call content and participant 
responses.  
 
Team changes 
Automated responses have been developed through a MDT, however delivery is via pre-recorded 
information. 
 
Patient education 
Different topics covered each week. Blood glucose monitoring was the first topic covered in each 
weekly call. It was followed by one of three other topics, including medication-taking, physical 
activity or healthy eating (calls 9-12 and 21-24). When diabetes medication was not prescribed, the 
medication-taking topic was replaced with physical activity. When clearance for physical activity was 
not provided by the patient’s treating physician, physical activity was replaced by medication-taking. 
In cases when there was no clearance for physical activity and no pharmaceutical treatment of 
diabetes, the participant did not hear a second topic on some calls. 
 
Case management 
Case management is not a focus of this programme. However the system is designed to support care 
currently being received by patients from their General Practitioner and/or other health 
professionals involved in diabetes management. 
 
Facilitated relay of information to primary clinician (role of technology) 
Automated- TLC’s responses, including feedback and encouragement, were tailored according to 
information entered in the TLC database at the start and the answers that it received from 
participants during all calls. 
 
Clearance for certain topic discussion (i.e. physical activity) was provided by the patient’s treating 
physician but it was unclear how this information was relayed to the service.  
 
Northern Alliance Hospital Admission Risk Programme 
The outer northern metropolitan region of Melbourne is a major suburban growth corridor. In 
recognition of the high prevalence of diabetes in this area, the Northern Alliance Hospital Admission 
Risk Programme (NA-HARP) established a chronic disease management programme for patients with 
poorly controlled diabetes (Rasekaba et al., 2012b).  
 
Patients eligible for this service were defined as patients with: an HbA1c>8.0 per cent; the presence 
of diabetes-related complications; or hospitalisation for diabetes management in the past 12 
months. The majority (90%) of clients enrolled in NA-HARP diabetes management have T2DM and an 
estimated 10 per cent have T1DM. Over a four year period, 967 patients were enrolled, and based on 
56 per cent of those, mean change in HbA1c after 12 months was 1.3 per cent (8.6% versus 7.3%) 
(Rasekaba et al., 2012a). In addition, significant improvements in HRQL measures were reported. 
 
For cost analyses, data were obtained from retrospective administrative records from 357 patients 
with diabetes who attended the NA-HARP for diabetes management between 1 September 2007 and 
Primary Health Care Research & Information Service 
phcris.org.au 
The role of primary health care in primary and secondary prevention of diabetes - 57 - 
31 May 2008. The majority of patients who enrolled in the programme accessed the Northern 
Hospital for acute hospital services (emergency and inpatient admissions). Hospital utilisation by the 
cohort was compared in the 12 months pre-enrolment, during programme enrolment and in the 12 
months post-completion of the programme. The cost of providing the diabetes service 
predominantly relates to staffing costs. Costs pertaining to staff annual salaries or hourly rates (salary 
plus 15% on-costs) for each staff member working in the diabetes service were obtained from 
administrative data. 
 
Cost outcomes: hospital utilisation related to primary diabetes and associated complications, as 
these episodes of care were more likely to be influenced directly by the diabetes programme. Of 
particular focus was the effect of a diabetes disease management service on acute care admission 
costs for patients with T2DM. The programme’s service delivery of 1,474 hours over nine months (4 
hrs per patient) delivered a low per-patient cost ($463 per patient). In contrast, the overall inpatient 
costs for the management of diabetes and related conditions were high and did not decrease 
significantly following programme completion. The major acute care cost drivers were surgical 
interventions for advanced peripheral vascular disease and the management of cardiovascular 
events. The cost modelling indicates that if diabetes management programmes are able to decrease 
admissions for vascular complications of diabetes the potential for cost savings can be realised. 
 
Self-management 
The service has integrated a self-management coaching approach into its model of care to assist 
clients in making the psycho-behavioural changes necessary to improve the control and management 
of their diabetes. 
 
Team changes 
Patients enrolled in the programme undergo a comprehensive, multidisciplinary team (MDT) 
assessment. Patients are provided with expert care from endocrinologists and allied health 
professionals including diabetes educators and dietitians. 
 
Patient education 
Individualised education is provided by diabetes educators and dietitians. 
 
Case management 
Based on the MDT assessment an individualised care plan is developed in consultation with the 
patient. 
 
Facilitated relay of information to primary clinician (role of technology) 
No details currently available. 
 
Logan Healthy Living Programme 
Living Well with Diabetes (LWWD) is a telephone-delivered weight loss and physical activity 
intervention designed for real-world delivery to Australian primary care patients with T2DM (Eakin et 
al., 2010, Eakin et al., 2013, Eakin et al., 2014). A RCT design was used to evaluate the LWWD over an 
18-month period, followed by a six-month non-contact maintenance follow-up period. Delivered 
entirely over the telephone, intervention combined increasing physical activity, reducing energy 
intake, and behavioural therapy through a maximum of 27 telephone calls over an 18-month period. 
Programme targets were ≥ five per cent weight loss, ≥210 min/week moderate-to-vigorous-
intensity physical activity (MVPA) and ≥2 MJ energy reduction. Primary outcomes were weight, 
accelerometer-derived MVPA, and HbA1c level. After 18 months intervention, modest but significant 
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improvements in weight loss (-1.42% of baseline body weight) and MVPA (42% higher than usual 
care), and more modest but significant changes in dietary quality and waist circumference were 
recorded. However, HbA1c, energy intake, cholesterol, triglyceride levels and blood pressure were 
not altered. After 18 months, 21 per cent of intervention and 13.2 per cent of usual care groups 
achieved the weight loss target; 34.8 per cent and 27.8 per cent, respectively, achieved the MVPA; 
and 22.8 per cent and 18.8 per cent achieved the energy reduction target. In the 6-month non-
contact maintenance follow-up (24-months), only MVPA remained significantly changed from 
baseline, with a 44 per cent greater MVPA or 38.95 min/week. Participation rates were lower than 
expected, with approximately 40 per cent of the intervention group discontinuing with the telephone 
calls and/or the study, and only half of those who continued receiving the intervention took 75 per 
cent or more of scheduled intervention calls.  
 
Self-management 
Participants were given a detailed workbook with guidelines on exercise sessions and options for 
progression to greater levels of activity than the minimum target. In addition to encouragement for 
generally increased levels of movement, a resistance band was given to members of the intervention 
group together with detailed photographs and instructions in the workbooks for completing 
resistance exercise sessions. Self-monitoring ‘trackers’ were also provided to monitor daily physical 
activity and food intake, with encouragement for daily self-weighing. The first six months focussed on 
initiating behavioural change and then the next 12 months on maintenance of change.  
 
Team changes 
Following identification of eligible patients through general practice medical records, qualified 
nutritionists delivered the telephone-based consultations and nurses performed the baseline, 6-
month, 18-month, and 24-month assessments. 
 
Patient education 
All patient education is conducted via telephone. Collaborative goals for weight, physical activity and 
dietary change were set with the telephone counsellor; the emphasis was placed on achievability and 
measurability. 
 
Case management 
All telephone counsellors have at least bachelor’s level training in nutrition and dietetics; some have 
also completed a dual-degree in exercise physiology. To the extent possible, the same telephone 
counsellor remains with participants throughout the duration of the intervention to facilitate rapport 
and continuity of care. Each telephone contact produces a behaviourally-specific action plan 
specifying what is to be done and when, barriers and supports are identified, confidence is assessed 
and problem-solving discussed as appropriate. 
 
Facilitated relay of information to primary clinician (role of technology) 
GPs were sent brief summaries of their patients’ assessment results. There was no information about 
the role of technology in the relay of this information. 
 
RADICAL 
The Rural Australian Diabetes – Inspiring Control Activity & Lifestyle’ (RADICAL) general practice 
based T1DM programme was launched in 2007 to provide proactive child and family emotional 
support (Goss et al., 2010). The RADICAL programme promotes insulin pump therapy and matching 
of therapy to the individual patient’s lifestyle. Over a two-year period, implementation of the 
RADICAL model resulted in a significant increase in annual number of contacts with credentialed 
diabetes educators, and reductions in HbA1c for children and adolescents, as well as improved 
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patient satisfaction and quality of life. In the year before RADICAL was launched, approximately six 
per cent of 48 patients achieved an HbA1c ≤7.5 per cent, and this increased to 36 per cent of 50 
patients in 2009; and emergency department attendance and admissions to hospital for diabetes-
related issues decreased from 23 per cent to eight per cent in 2008 (Goss et al., 2010).   
 
Self-management 
In addition to promoting the use of insulin pumps, the RADICAL team supported patient use and self-
management.  
 
Team changes 
The RADICAL model is based on a co-located core multidisciplinary team (GP, diabetes educator, 
mental health nurse/counsellor). According to the study group, an important contributor to the 
success of RADICAL was the inclusion of a counsellor as part of the core team. With expertise in child 
behaviour, family loss, grief, and trauma counselling, their role was to address the psychosocial 
needs of the child and family.  
 
Patient education 
Not indicated. 
 
Case management 
Patients were organised into three monthly 20-minute clinic appointments with team case meetings 
on each individual patient taking place on the same day. 
 
Facilitated relay of information to primary clinician (role of technology) 
Not indicated. 
 
Diabetes Management Along the Mallee Track 
The Diabetes Management Along the Mallee Track incorporates community risk assessment and 
point-of-care testing (PoCT) to manage rural patients at risk for or with diagnosed diabetes (T1DM 
and T2DM) in partnership with local GPs, allied health and community health nurses (Shephard et al., 
2005). This service was offered irrespective of diabetes type and after 10 months the percentage of 
people achieving good glycaemic control (HbA1c<7%) increased from 33 to 63 per cent; and 
achieving adequate control (HbA1c<8%) increased from 59 per cent to 91 per cent. PoCT diabetes 
management programmes have been implemented in a number of rural and urban settings, 
including Aboriginal and Torres Strait Islander communities, and an accreditation programme has 
been established for ongoing implementation (Shephard, 2006). This study was based on only 55 
people and should be interpreted with caution. 
 
Self-management 
Not described. 
 
Team changes 
GPs were assisted by allied health and community health nurses. This included locally engaged 
podiatrists and visiting diabetes educators. 
 
Patient education 
Educational training and resources were provided by the Flinders’ community Point of Care services 
for community health nurses, but no mention was made of patient education. 
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Case management 
Follow-up for people identified at greatest risk for diabetes (and presumably diabetes-related 
complications) was flagged as a key challenge. 
 
Facilitated relay of information to primary clinician (role of technology) 
A central register of programme participants was established and maintained by the Flinders’ 
community Point-of-Care services unit and electronically updated and made available to local GPs. 
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International secondary prevention programmes 
 
Diabetes, Your Life, Your Journey programme 
The Your Life Your Journey programme is a structured, group-based diabetes self-management 
education (DSME) programme for people, families and whanau with T2DM in New Zealand (Krebs et 
al., 2013). An observational study design was employed to assess outcomes at baseline, three, six 
and 12 months following programme delivery. The primary outcome was HbA1c with other outcome 
measures including: lipid profile, blood pressure, weight, smoking status and urinary 
microalbumin:creatinine ratio (UACR). 
 
Routine clinical data were collected from the PHC records at baseline, three, six and nine months 
(Krebs et al., 2013). Glycaemic control improved between baseline and six months (HbA1c 
64.9±20.0mmol/mol to 59.9±13.9mmol/mol (p<0.05) (baseline 8.07%±1.80, 6 months 7.62%±1.25)), 
but was no different to baseline at nine months. Systolic BP reduced from 131.9±16.4 to 
127.4±18.2mmHg (p<0.05) at six months, but increased to baseline levels by nine months. Diastolic 
BP, triglycerides and UACR were significantly reduced at three, six and nine months.  
 
The dilution of improvements after six months suggests a refresher course at that time may be 
beneficial. Results are based on an observational study design, with no control group.   
 
Self-management 
Self-management was group-based, and included family/whanauv. The programme is based on three 
accredited diabetes education programs developed in the UK (see EMIS), the Dose Adjustment for 
Normal Eating (DAFNE), Diabetes Education and Self-Management for Ongoing and Newly Diagnosed 
(DESMOND), and the X-PERT programmes. The NZ programme has been tailored for the unique social 
and ethnic environment of New Zealand using concepts from internationally developed programmes. 
 
Team changes 
The programme does not require a great deal of team changes but it is able to be delivered in a 
primary care or community setting. Sessions were delivered by a dietician, with either a practice 
nurse from primary care or diabetes nurse specialist from primary or secondary care. 
 
Patient education 
This programme focuses on group-based education for self-management. All sessions include a range 
of interactive activities, visual aids and demonstrations. At each session, participants are asked to set 
a goal and this is reviewed at the beginning of each session. 
 
Over six weeks, eligible patients undertake an introduction to diabetes including defining what 
diabetes is and how it is managed with the use of emotion cards and hyperglycaemia symptoms to 
discuss diagnosis (week 1); and discussion on the balance between food, activity, medication and the 
health care team. Information on food classification activities, carbohydrate and glycaemic index; the 
influence of food on blood lipids, weight management, label reading, alcohol, diet review, and 
activity (weeks 2/3) is also covered. One session allows exploration of things patients have control 
over including physical activity, smoking, blood pressure, cholesterol, blood glucose levels, 
medications including insulin, urine tests and healthy coping approaches (week 4). Management of 
poor health or ‘sick days’ is discussed (week 5) including hyper-and hypo-glycaemia and what can be 
done to prevent complications. A summary and review session concludes the programme (week 6). 
                                                          
v Whanau is a Maori language word meaning extended family or family community. 
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Case management 
There is very little case-management in this programme apart from identification of eligibility and 
referral to the programme. 
 
Facilitated relay of information to primary clinician (role of technology) 
There were no formal arrangements for the relay of information between programme and other 
health professionals. Participants were recruited through primary care networks, community 
diabetes organisations and through secondary care specialist diabetes nurses and physicians.  
 
Healthy Eating and Active Living in Diabetes 
Healthy Eating and Active Living in Diabetes (HEALD-PCN) is a pedometer-based walking programme. 
The programme consists of two 12-week phases with an emphasis on physical activity (walking). 
 
The HEALD-PCN intervention is based on a previously pilot-tested self-management programme in a 
small (N = 41) RCT (Johnson et al., 2009). The primary outcomes for this study were steps-per-day. 
Secondary outcomes included energy intake, weight, BMI and systolic and diastolic blood pressure 
and resting pulse rate. Participants were randomized to either basic lifestyle programme or an 
enhanced lifestyle programme (ELP). Assessment after 12 weeks indicated a statistically significant 
increase in average total daily steps of 1,562 (95% confidence interval: 303–2821, p = 0.02) 
regardless of group allocation. Weight (mean change -0.9 kg, approximately 1.0%), BMI and systolic 
(mean change -6.0 mmHg) and diastolic blood pressure (mean change -5.2 mmHg) also improved for 
all participants. No changes were observed for energy intake. At week 24, those in the ELP had a 
lower resting PR (71 ± 12 bpm.) compared with those in the basic lifestyle programme (78 ± 12 
bpm.). No group differences were observed for total daily steps or glycaemic control. 
 
A study is currently underway (Johnson et al., 2012b) to assess efficacy in a larger sample of people 
with T2DM. The primary outcome will be physical activity determined by self-report using questions 
from the International Physical Activity Questionnaire and pedometers. Secondary outcomes include 
HbA1c, lipid profile, glucose, resting heart rate, blood pressure and BMI. Measure of nutrition 
behaviour was also recorded using a food frequency questionnaire. 
 
Self-management 
Key features of HEALD-PCN include the provision of information in a group setting by an exercise 
specialist on increasing the amount and intensity of physical activity (i.e. walking), the glycaemic 
index and individual goal setting. As part of phase 1, during weeks 1 and 2, participants attend a 30-
minute, group-based meeting, including a supervised walking session, facilitated by the Exercise 
Specialist, and located in facilities in the community. A pedometer, a resource manual and step 
logbook is provided at the first meeting as a means to facilitate goal setting and to record the total 
number of steps/day. 
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Team changes 
Exercise specialist.  
 
Patient education 
Pacing techniques are taught during phase 2. In weeks 13 and 14, participants attend two more 
group-based meetings at the same community-based facility, where they are taught by the Exercise 
Specialist how to increase their walking speed by 10 per cent during a 30-minute walk. The 
participants are then asked to incorporate this faster walking pace for 30 minutes/day on three 
days/week on their own, until the end of the study period. For example, if a participant’s self-
selected walking pace was 90 steps/minute, they will be encouraged to increase his or her pace to 
approximately 100 steps/minute. Participants will be asked to perform their faster walking in bouts 
lasting no less than 10 minutes, and will be given a second pedometer and a stopwatch to help them. 
 
Case management 
Not applicable 
 
Facilitated relay of information to primary clinician (role of technology) 
Not applicable. 
 
TeamCare model 
The TeamCare model (TeamCare-PCN) (Johnson et al., 2012a) is a collaborative team-based, 
depression case management intervention. It was initiated in four Primary Care Networks in 
Northern Alberta, Canada. Key features of TeamCare-PCN include coordinated care by a nurse care 
manager to direct active patient follow-up, treat-to-target principles and specialist (i.e. psychiatrist 
and internists/endocrinologists) consultation. 
 
This programme has been evaluated in a RCT of participants with chronic conditions. It has been 
trialled in participants with poorly controlled diabetes, coronary heart disease or both, coexisting 
with depression. At 12 months, patients in the intervention group had significantly greater overall 
improvement compared with controls with respect to HbA1c (-0.56 % vs control), LDL cholesterol (-
9.1 mg/dl vs control), systolic blood pressure (-3.4 mmHg vs control); and telephone interviews were 
undertaken at six month intervals to assess depression symptoms, health risk behaviour and 
satisfaction with care of depression and diabetes/coronary heart disease or both (Katon et al., 2010). 
 
A study is currently underway (Johnson et al., 2012a) based on the Katon et al. (2010) trial. Primary 
outcomes target depressive symptoms and a multivariable, scaled marginal model for the combined 
outcome of global disease control (i.e. HbA1c, systolic blood pressure, LDL cholesterol) and chronic 
disease-related clinical outcomes. Process indicators will include the number of visits with PCN care 
providers, including case manager, family physicians, specialists’ consults, referrals for mental health 
care, and use of medications and psychotherapeutic sessions. The time spent with patients, 
adjustments to medications and adherence to treatments will also be assessed. 
 
This programme has three phases: depression management; stepped care/treat to target; and 
patient education.  
1) Improving depressive symptoms, Depression management with antidepressants and/or 
psychotherapy. Direct referral to the care of a psychiatrist will occur only on failure of two 
separate trials of antidepressants, or one trial of antidepressant in combination with 
psychotherapy. When patients have reached remission, the case manager and patient work 
Primary Health Care Research & Information Service 
phcris.org.au 
The role of primary health care in primary and secondary prevention of diabetes - 64 - 
together towards a relapse prevention plan to help the patient identify when and where to 
seek help with future depressive symptoms or renewed problems for disease control. 
2) Improving blood glucose, blood pressure and cholesterol, cardio-metabolic diabetes 
management (Stepped care/treat-to-target algorithms). Recommended treatments have 
been based on algorithms that were developed in collaboration with the PCNs by compiling 
various guidelines and sources, such as extant clinical practice guidelines and consulting 
experts in the field. Phase 2 includes working with the care manager in analogous fashion to 
Phase 1, but with a focus on reaching individualised targets for HbA1c, lipids and blood 
pressure measures. 
3) Improving lifestyle behaviours. Lifestyle modifications (algorithms based on local and 
national guidelines). Phase 3 involves patient education to address lifestyle behaviours such 
as diet and exercise. Locally developed educational materials and existing PCN support 
programmes will be available for patient referrals. 
 
Self-management 
The intervention combines support for self-care with pharmacotherapy to control depression, 
hyperglycaemia, hypertension, and hyperlipidaemia. Patients worked collaboratively with nurses and 
primary care physicians to establish individualised clinical and self-care goals. 
 
Team changes 
Nurse care managers guide the patient-centred care with family physicians and consultant physician 
specialists to monitor progress and develop tailored care plans. 
 
A two-day training session for case managers and consultant specialists was scheduled at the 
beginning of the project, with an annual one-day booster session. Case managers were provided with 
basic training in three psychotherapeutic techniques: problem-solving therapy, behavioural 
activation, and motivational interviewing. 
 
Patient education 
Education is a large part of this programme. The case manager’s role is to partner with the patient to 
develop a shared definition of problems, provide education, support, negotiated specific 
targets/goals and to develop an individualised action plan. In particular, Phase 3 involves patient 
education to address lifestyle behaviours such as diet and exercise. Locally developed educational 
materials and existing PCN support programmes will be available for patient referrals. 
 
Case management 
A two-hour baseline appointment with the case manager for a bio-psychosocial semi-structured 
assessment (reviewing medical history, previous treatments for depression and diabetes), patient 
education, potential treatment options (antidepressant medications and/or psychotherapy) and 
developing a personalised care plan.  
 
Structured visits in each patient’s primary care clinic every two to three weeks, where nurses 
monitor patient progress with respect to management of depression (according to the PHQ-9vi 
score), control of medical disease, and self-care activities. Treatment protocols guided adjustments 
of commonly used medicines in patients who did not achieve specific goals. 
 
  
                                                          
vi Patient health questionnaire is a self-administered screening and diagnostic tool for mental health disorders.  
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Facilitated relay of information to primary clinician (role of technology) 
Nurse care managers actively follow up with patients by telephone or in person one to two times per 
month to re-assess symptoms, and assist and support patients in achieving treatment goals. The care 
manager will also have weekly meetings with the consulting specialists to review new cases and 
patient progress, and then communicate team treatment recommendations to the primary care 
physician. This includes a visit with the care manager or follow-up by phone; and a meeting with 
consulting specialists and family physician on a weekly basis or as needed. 
 
The St. Joseph’s Primary Care Diabetes Support Programme 
The St. Joseph’s Primary Care Diabetes Support Programme (SJHC PCDSP) (Reichert et al., 2014) is 
part of the Ontario Diabetes Strategy-funded Diabetes Education Programme in London, Ontario. The 
programme was developed with the main objective of providing diabetes management for a variety 
of patients (over 90% T2DM) including those with multimorbidities (CVD, heart disease, stroke, 
myocardial infarction, transient ischemic attacks, neuropathy, nephropathy, fatty-liver and 
amputation), complex social determinants of health not well served by usual care (i.e. poverty, 
psychiatric medical histories, no health coverage, language barriers, multiple stressors and mobility 
issues), and individuals with no family physician. 
 
The primary outcome measured was HbA1c, which was at baseline on average, 9.36 per cent and 
8.61 per cent for patients with T1DM and T2DM, respectively. However, by six months, HbA1c was 
lowered by 1.15 per cent for patients with T1DM and by 0.87 per cent for patients with T2DM. Other 
important health outcomes, including blood pressure, dyslipidaemia and weight, are also routinely 
examined, and results revealed improvements over time. 
 
Self-management 
Weekly contacts are established for insulin titration when a patient starts on insulin or a new 
medication that may require follow-up. Staff schedules reserve a number of these 15-minute spots to 
complete this work. Principles of self-management are reinforced during these encounters as 
patients are often taught how to test with purpose or to make connections between insulin action 
and dietary choices.  
 
Remote support allows patients to communicate either by e-mail, phone or fax with allied health 
staff.  
 
Team changes 
The main feature of this programme which is considered unique beyond patient self-management 
skills, as offered in traditional Diabetes Education Programmes, is the active medical management 
provided by an expanded care team that includes primary care physicians and nurse practitioners 
specialised in primary care and diabetes management. Patients have access to a variety of healthcare 
professionals, including three physicians, two full-time nurse practitioners, two part-time nurses, two 
dietitians and one social worker.  
 
Patient education 
The social worker facilitates a behaviour-modification group focused on eating behaviours called 
“Craving Change”, while volunteer undergraduate and master’s programme kinesiology students 
offer weekly exercise group programmes. 
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Case management 
All nurses and dietitians are certified diabetes educators. The nurse practitioners have an extended 
class license allowing them to prescribe and manage a subset of patients independently. 
 
Facilitated relay of information to primary clinician (role of technology) 
Physically co-located within the same building as a family health team, it serves patients referred 
from the family health team, and community referrals from a variety of providers and practice 
settings (i.e. post-hospital discharge, emergency departments, walk-in clinics, other health-care 
providers such as chiropodists, and patient self-referrals). 
 
Further relay of information if supported by all assessments are structured using a standardised 
EMR-supported format. All electronic encounter notes are read and verified by the physician of the 
day. A case-management approach with relevant physician input ensures that patients have 
providers most knowledgeable about their care and the opportunity to involve additional expertise 
as required during any given visit. 
 
Clinical care is supported by WebDR, a unique EMR developed for diabetes outpatient clinics. It was 
built after determining that commercial EMR vendors did not offer an EMR that fully suited practice 
demands. All relevant clinical data are housed in the EMR which, in turn, promotes team-based care. 
It can also be used as a researchable database and now houses more than 15,000 unique patient 
records. 
 
Intermediate Care Clinics for Diabetes 
Intermediate Care Clinics for Diabetes (ICCD) are integrated diabetes service in a ‘hub and spoke’ 
model between primary and specialist services to utilise the specialist expertise economically and 
provide opportunity for regular ‘up skilling’ the knowledge of primary care practitioners (Sharp, 2010, 
Halfyard et al., 2010). These are community based, MDTs, working closely with general practices.  
 
A pragmatic two-arm cluster RCT in three English PCTs (Wilson et al., 2014) has been undertaken in 
an urban setting of the East and West Midlands of the UK. Adults were aged 18 years or over, 
diagnosed with T2DM, with no severe cognitive impairment, no severe mental illness and not 
receiving terminal care. 
 
Outcomes: Combined control (reaching all targets HbA1c, BP and total cholesterol), individual risk 
factors (HbA1c, BP and cholesterol). Secondary outcomes comprised the proportion of participants 
reaching targets for individual factors (HbA1c, BP and total cholesterol), HRQL and the incremental 
cost of the programme was estimated. 
 
At follow-up (12 months post discharge from the clinic) 14.3 per cent of patients in the intervention 
group compared with 9.3 per cent in the control group achieved combined control. Intervention 
group patients were more likely to achieve control of HbA1c (mean change 1.5%) and total 
cholesterol at follow-up. The total cost of care per patient (including diagnostic tests and hospital 
inpatient stay) was higher in the intervention group, but did not reach statistical significance. Quality 
of life was not impacted.  
 
The recruited sample for this study had poor HbA1c control at baseline (mean HbA1c 10.1%) 
Sharing information: In PCTs 1 and 2, an active ‘case finding’ approach was used in which members of 
the ICCD team searched GP records to identify those with suboptimal risk factor control who may 
benefit from referral. Although the ICCD service in PCT 3 visited practices to promote the clinics, it 
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relied on primary care practitioners identifying suitable patients for referral. Two intervention 
practices refused access for follow-up assessment and including these, a total of 528 patients were 
lost to follow-up (intervention–324; control–204). A further 189 patients were excluded from 
analysis (intervention–89; control–100) due to incomplete data. Thus, data from 68 per cent of the 
control group (636/940) and 61 per cent of the 644/1057) intervention group were available for final 
analyses. 
 
Self-management 
Emphasis on self-management. 
 
Team changes 
Clinics work closely with hospital-based specialist teams and community services, including podiatry 
and dietetic services. The community-based MDT is led by a diabetes specialist nurse, consultant or 
GP with specialist interests. Investigation has been recommended into organisational structure and 
ideal scale of ICCD services as they are linked to skill levels of the general practitioners involved 
(Wilson et al., 2014).  
 
Patient education 
Emphasis on education and direct work with patients and practice education. 
 
Case management 
Proactive ‘case finding’ approach used in two and use of MDTs in all three PCTs represent first steps 
towards case management. Patients were managed by the ICCD team until control of risk factors was 
achieved and then referred back to primary care. Teams worked to NICE guidelines on targets for 
HbA1c, lipids, and blood pressure. 
 
Facilitated relay of information to primary clinician (role of technology) 
Triaged hospital referrals. Providing practices with access to an ICCD service led to an increase in the 
proportion of patients achieving targets for control as assessed by a primary outcome measure. 
However without a ‘case-finding’ approach (i.e. predictive risk model) there is a risk that ICCD 
services may be under-utilised. The current arrangement relies on strong relationships with local 
practices to promote the use of the service(s).  
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Ongoing secondary prevention programme trials without 
outcomes data 
 
Diabetes Care Project 
The Diabetes Care Project (Leach et al., 2013) is a three-year, pragmatic, cluster RCT designed to 
evaluate the impact of two interventions on diabetes care delivered to adults in general practice: 
1.  Access to the online CDMt network (cdmNet) and access to training and capability building 
2. Access to cdmNet with the addition of patient risk stratification, provision of a care 
facilitator, access to training and capability building, new funding model including rewards 
for improvement and care facilitator support. 
 
Developed by a consortium of 20 organisations from across Australia, the programme features were 
based on published evidence for interventions shown to improve glycaemic control and, in line with 
this, change in HbA1c is the primary endpoint for the trial. In group 2, care delivery is based on a 
MDT including GPs and the care facilitator, and other professionals depending on patient needs. All 
carers use the cdmNet tool to coordinate deliver of care. Risk stratification affects the care plan that 
is generated for a patient, the risk categories are: not complex and within range; complex and within 
range; not complex and out of range; complex and out of range. Out of range refers to the level of 
control for HbA1c, SBP, and serum cholesterol. 
 
The new funding model includes a number of innovations (Cheng): flexible funding for GP care 
planning; flexible funding for Allied Health Professional services; pay-for-performance payments to 
general practice for improvement in patient outcomes and meeting defined levels of patient 
experience and clinical processes; and funding to support organisation development such as training 
and resourcing. 
 
The trial commenced in 2012, and a total of 150 practices have been enrolled and the planned end 
date for the trial is June 2014. No outcome data are currently available. 
